metronidazole has been researched along with Gastritis in 264 studies
Metronidazole: A nitroimidazole used to treat AMEBIASIS; VAGINITIS; TRICHOMONAS INFECTIONS; GIARDIASIS; ANAEROBIC BACTERIA; and TREPONEMAL INFECTIONS.
metronidazole : A member of the class of imidazoles substituted at C-1, -2 and -5 with 2-hydroxyethyl, nitro and methyl groups respectively. It has activity against anaerobic bacteria and protozoa, and has a radiosensitising effect on hypoxic tumour cells. It may be given by mouth in tablets, or as the benzoate in an oral suspension. The hydrochloride salt can be used in intravenous infusions. Metronidazole is a prodrug and is selective for anaerobic bacteria due to their ability to intracellularly reduce the nitro group of metronidazole to give nitroso-containing intermediates. These can covalently bind to DNA, disrupting its helical structure, inducing DNA strand breaks and inhibiting bacterial nucleic acid synthesis, ultimately resulting in bacterial cell death.
Gastritis: Inflammation of the GASTRIC MUCOSA, a lesion observed in a number of unrelated disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This double-blind, randomized, phase III clinical trial was carried out in two parallel groups to assess the efficacy of ebrotidine (N-[(E)-[[2-[[[2-[(diaminomethylene) amino]-4-thiazolyl]methyl]thio]ethyl]amino] methylene]-4-bromo-benzenesulfonamide, CAS 100981-43-9, FI-3542) 400 mg and ranitidine 300 mg given in single evening dose, combined with amoxicillin 750 mg and metronidazole 500 mg three times daily for 14 days, in the eradication of Helicobacter pylori in patients with duodenal ulcer." | 9.08 | Efficacy of ebrotidine and ranitidine combined with amoxicillin and metronidazole in the eradication of Helicobacter pylori in patients with duodenal ulcer. ( Fillat, O; Herrero, E; Karcz, D; Kulig, J; Márquez, M; Ortiz, JA; Popiela, T; Tabor, J; Torres, J, 1997) |
| "Rabeprazole is a new fast acting proton pump inhibitor that has recently been proven to be effective in the treatment of peptic ulceration and reflux esophagitis." | 9.08 | Safety and efficacy of rabeprazole in combination with four antibiotic regimens for the eradication of Helicobacter pylori in patients with chronic gastritis with or without peptic ulceration. ( Atherton, JC; Cockayne, A; Hawkey, CJ; Jenkins, D; Knifton, A; Stack, WA; Thirlwell, D, 1998) |
| "Two 4-week triple-therapy treatment regimens, metronidazole+tetracycline+bismuth subcitrate and omeprazole+amoxycillin+bismuth subcitrate, were compared in a randomly allocated double-blind trial for their efficacy in eradicating Helicobacter pylori from the gastric mucosa of patients with gastritis and/or peptic ulcer disease." | 9.07 | Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease. ( Hahm, JS; Kim, HJ; Park, KN, 1994) |
| "Seventy-two patients with Helicobacter pylori-associated chronic gastritis were randomized to a 3-week oral treatment with furazolidone 0." | 9.06 | The efficacy of furazolidone and metronidazole in the treatment of chronic gastritis associated with Helicobacter (Campylobacter) pylori--a randomized double-blind placebo-controlled clinical trial. ( Jiang, SJ; Liu, WZ; Wang, RN; Xia, DH; Xiao, SD; Xu, WW; Zhang, ZH, 1990) |
| " We attempted to investigate the role of clarithromycin with tinidazole on Helicobacter pylori-related gastritis from the aspects of clinical effect and COX-2 expression." | 8.02 | Clinical Effect of Clarithromycin Combined with Tinidazole on Helicobacter pylori-Related Gastritis and Its Influence on COX-2 Expression. ( He, C; Kong, F; Liu, Y; Wang, K; Zhao, W; Zhu, X, 2021) |
| "Six captive cheetahs (Acinonyx jubatus) with severe gastritis diagnosed by gastric endoscopy and mucosal histopathology were treated with omeprazole, metronidazole, and amoxicillin for 3 wk." | 7.72 | Treatment with omeprazole, metronidazole, and amoxicillin in captive South African cheetahs (Acinonyx jubatus) with spiral bacteria infection and gastritis. ( Burroughs, R; Lane, E; Lobetti, R, 2004) |
| " Helicobacter pylori associated gastritis patients were randomized to 2 groups: group 1 (n=100) was tailored triple therapy with placebo (esomeprazole 20 mg bid, clarithromycin 500 mg bid or metronidazole 400 mg tid if clarithromycin resistance and amoxicillin 1000 mg bid), and group 2 was tailored triple therapy plus pretreatment with probiotic containing yogurt." | 5.20 | Effect of Pretreatment with Lactobacillus delbrueckii and Streptococcus thermophillus on Tailored Triple Therapy for Helicobacter pylori Eradication: A Prospective Randomized Controlled Clinical Trial. ( Dechsukhum, C; Kaewpitoon, N; Kaewpitoon, S; Leeanansaksiri, W; Loyd, RA; Matrakool, L; Panpimanmas, S; Tongtawee, T, 2015) |
| "One hundred and eight patients with pangastritis were assigned to either lansoprazole 30 mg once a day (n=54) or bismuth 240 mg bis in die (n=54) for 14 days combined, for the first week, with amoxicillin 1g plus metronidazole 250 mg tris in die." | 5.14 | High efficacy of bismuth subcitrate for Helicobacter pylori eradication in pangastritis. ( Abdullahi, M; Annibale, B; Capoccia, D; Leonetti, F; Marcheggiano, A; Osborn, J; Severi, C; Tari, R; Vannella, L, 2009) |
| "Treatment of H pylori can enhance the efficacy of ferrous succinate therapy in IDA patients with H pylori-positive chronic gastritis." | 5.12 | Effects of H pylori therapy on erythrocytic and iron parameters in iron deficiency anemia patients with H pylori-positive chronic gastristis. ( Chen, LH; Luo, HS, 2007) |
| " pylori associated gastritis were randomly divided into pantoprazole triple regimen group (pantoprazole 40 mg, amoxicillin 1 g, and metronidazole 400 mg, bid,for 1-week or 2-weeks) and omeprazole triple regimen (omeprazole 20 mg, amoxicillin 1 g, and metronidazole 400 mg, bid, for 1-week or 2-weeks)." | 5.10 | [Comparison of pantoprazole and omeprazole-based triple therapy regimens in the treatment of Helicobacter pylori infection]. ( Cui, M; Hu, F; Jiang, H; Zheng, X, 2002) |
| " All patients belong to a low socioeconomic strata, had multifocal atrophic gastritis documented by gastric biopsies, and had been treated previously and unsuccessfully for 2 weeks with bismuth subsalicylate (262 mg four times a day), amoxicillin (500 mg three times a day), and metronidazole (400 mg three times a day)." | 5.09 | Eradication of Helicobacter pylori infection with proton pump-based triple therapy in patients in whom bismuth-based triple therapy failed. ( Bravo, LE; Correa, P; DeLany, JP; Mera, R; Realpe, JL, 1999) |
| " Patients (n = 787) with proved duodenal ulcer disease were randomized to treatment twice daily for 1 week with omeprazole, 20 mg (O), plus either placebo (P) or combinations of two of the following antimicrobials: amoxicillin, 1 gm (A), clarithromycin, 250 or 500 mg (C250, C500), or metronidazole, 400 mg (M)." | 5.08 | Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study. ( Bardhan, KD; Bayerdörffer, E; Bradette, M; Cederberg, C; Chiba, N; Idström, JP; Lind, T; O'Morain, C; Spiller, R; Unge, P; Veldhuyzen van Zanten, S; Wrangstadh, M, 1996) |
| "This double-blind, randomized, phase III clinical trial was carried out in two parallel groups to assess the efficacy of ebrotidine (N-[(E)-[[2-[[[2-[(diaminomethylene) amino]-4-thiazolyl]methyl]thio]ethyl]amino] methylene]-4-bromo-benzenesulfonamide, CAS 100981-43-9, FI-3542) 400 mg and ranitidine 300 mg given in single evening dose, combined with amoxicillin 750 mg and metronidazole 500 mg three times daily for 14 days, in the eradication of Helicobacter pylori in patients with duodenal ulcer." | 5.08 | Efficacy of ebrotidine and ranitidine combined with amoxicillin and metronidazole in the eradication of Helicobacter pylori in patients with duodenal ulcer. ( Fillat, O; Herrero, E; Karcz, D; Kulig, J; Márquez, M; Ortiz, JA; Popiela, T; Tabor, J; Torres, J, 1997) |
| " pylori-infected patients with endoscopically documented duodenal ulcer either currently or within the past year were randomized to 14 days of (1) lansoprazole, 30 mg bid, plus amoxicillin, 1 gm tid; (2) lansoprazole, 30 mg tid, plus amoxicillin, 1 gm tid; (3) lansoprazole, 30 mg tid alone; or (4) amoxicillin, 1 gm tid alone." | 5.08 | Double-blind, multicenter evaluation of lansoprazole and amoxicillin dual therapy for the cure of Helicobacter pylori infection. ( Arora, A; Graham, D; Haber, M; Harford, W; Lanza, F; Rose, P; Siepman, N; Weissfeld, A, 1996) |
| " pylori-positive gastritis with or without peptic ulcer, and compared with the classic 'Bazzoli regimen' (OCT: omeprazole, clarithromycin, tinidazole) in 60 matched patients." | 5.08 | Short-term low-dose triple therapy with azithromycin, metronidazole and lansoprazole appears highly effective for the eradication of Helicobacter pylori. ( Alvisi, V; Caselli, M; Gasbarrini, G; Gaudenzi, P; Luzzi, I; Ruina, M; Sartori, S; Trevisani, L; Tursi, A, 1997) |
| "The aim of this study was to assess the effect of colloidal bismuth subcitrate (CBS) and metronidazole on Helicobacter pylori eradication and on the course of symptoms due to functional dyspepsia." | 5.08 | Eradication of Helicobacter pylori and long-term outcome of functional dyspepsia. A clinical endoscopic study. ( Bargiggia, S; Bianchi Porro, G; Boldorini, M; Lazzaroni, M; Maconi, G; Sangaletti, O, 1996) |
| "The combined therapy with amoxycillin, metronidazole, and omeprazole is highly effective in both HP eradication and prevention of duodenal ulcer recurrence." | 5.08 | Omeprazole coupled with two antibiotics for Helicobacter pylori eradication and prevention of ulcer recurrence. ( Alvisi, C; Bargiggia, S; Bianchi Porro, G; Cesana, B; Fiocca, R; Franceschi, M; Lazzaroni, M; Luinetti, O; Maconi, G; Perego, M; Solcia, E; Trespi, E; Villani, L, 1996) |
| "Rabeprazole is a new fast acting proton pump inhibitor that has recently been proven to be effective in the treatment of peptic ulceration and reflux esophagitis." | 5.08 | Safety and efficacy of rabeprazole in combination with four antibiotic regimens for the eradication of Helicobacter pylori in patients with chronic gastritis with or without peptic ulceration. ( Atherton, JC; Cockayne, A; Hawkey, CJ; Jenkins, D; Knifton, A; Stack, WA; Thirlwell, D, 1998) |
| "Lansoprazole-based quadruple therapy achieves a very high cure rate in an unselected population of either peptic ulcer patients or those with H." | 5.08 | Lansoprazole quadruple therapy is effective in curing Helicobacter pylori infection. ( Bolin, TD; Engelman, JL; Korman, MG; Nicholson, FB, 1998) |
| " The aim of this study was to determine whether the carbon 13-labeled urea breath test (UBT) can be used in children by evaluating: (1) its sensitivity and specificity compared with either culture or both rapid urease test and histologic examination, (2) whether a test meal or a prolonged fast is required, (3) the usefulness after treatment for H." | 5.08 | Carbon 13-labeled urea breath test for the diagnosis of Helicobacter pylori infection in children. ( Daly, LE; Drumm, B; Durnin, M; Gormally, S; Hetherington, C; Lambert, I; Rowland, M; Thomas, JE, 1997) |
| "pylori positive (histology and/or culture) ulcer disease (n = 17; acute ulcer: n = 11) or functional dyspepsia (n = 13) were treated over one week with pantoprazole 40 mg bd, clarithromycin 250 mg bd and metronidazole 400 mg bd." | 5.08 | [Short-term triple therapy with pantoprazole, clarithromycin and metronidazole in eradication of Helicobacter pylori]. ( Becker, T; Börsch, G; Labenz, J; Peitz, U; Stolte, M; Tillenburg, B, 1995) |
| " Forty-six consecutive patients (suffering from either peptic ulcer or non-ulcer dyspepsia) with helicobacter pylori infection were randomly allocated to one of the following two groups: group 1 (n = 23) 2 weeks of treatment with bismuth subcitrate tablets (120 mgx4) + amoxycillin capsules (500 mgx4) + metronidazole tablets (250 mgx4); group 2 (n = 23) 2 weeks of treatment with amoxycillin capsules (500 mgx4) + metronidazole tablets (250 mgx4)." | 5.07 | Evaluation of two therapeutic regimens for the treatment of Helicobacter pylori infection. ( Corinaldesi, R; De Giorgio, R; Gasperoni, S; Paparo, GF; Poli, L; Stanghellini, V; Tucci, A; Varoli, O, 1994) |
| "Two 4-week triple-therapy treatment regimens, metronidazole+tetracycline+bismuth subcitrate and omeprazole+amoxycillin+bismuth subcitrate, were compared in a randomly allocated double-blind trial for their efficacy in eradicating Helicobacter pylori from the gastric mucosa of patients with gastritis and/or peptic ulcer disease." | 5.07 | Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease. ( Hahm, JS; Kim, HJ; Park, KN, 1994) |
| " pylori-associated gastritis were allocated to one of the following four therapeutic schedules: 1) omeprazole 40 mg/d for 4 weeks (n = 13); 2) bismuth subsalicylate (BSS) 3 x 600 mg for 4 weeks (n = 12); 3) omeprazole plus BSS for 4 weeks (n = 13); 4) triple therapy (BSS for 4 weeks, amoxicillin 3 x 750 mg and metronidazole 3 x 400 mg for 10 days) (n = 12)." | 5.07 | The role of omeprazole (40 mg) in the treatment of gastric Helicobacter pylori infection. ( Bär, W; Gebel, M; Haruma, K; Lange, P; Müller, MJ; Schorn, T; Soudah, B; Varrentrapp, M; Wagner, S, 1991) |
| " pylori-positive patients with (n = 42) or without (n = 42) duodenal ulcer were randomized to receive ranitidine, bismuth, or bismuth plus antibiotics." | 5.07 | Surface hydrophobicity of gastric mucosa in Helicobacter pylori infection: effect of clearance and eradication. ( Corbishley, CM; Goggin, PM; Jackson, PA; Marrero, JM; Northfield, TC; Spychal, RT, 1992) |
| "Seventy-two patients with Helicobacter pylori-associated chronic gastritis were randomized to a 3-week oral treatment with furazolidone 0." | 5.06 | The efficacy of furazolidone and metronidazole in the treatment of chronic gastritis associated with Helicobacter (Campylobacter) pylori--a randomized double-blind placebo-controlled clinical trial. ( Jiang, SJ; Liu, WZ; Wang, RN; Xia, DH; Xiao, SD; Xu, WW; Zhang, ZH, 1990) |
| " We attempted to investigate the role of clarithromycin with tinidazole on Helicobacter pylori-related gastritis from the aspects of clinical effect and COX-2 expression." | 4.02 | Clinical Effect of Clarithromycin Combined with Tinidazole on Helicobacter pylori-Related Gastritis and Its Influence on COX-2 Expression. ( He, C; Kong, F; Liu, Y; Wang, K; Zhao, W; Zhu, X, 2021) |
| " pylori culture positive dyspeptic patients (64 patients with peptic ulcer, PU) completed a 2-week treatment with omeprazole, amoxicillin and metronidazole and underwent endoscopy again 6-8 weeks after the end of therapy." | 3.78 | Factors modulating the outcome of treatment for the eradication of Helicobacter pylori infection. ( Figura, N; Giordano, N; Langone, F; Moretti, E; Vaglio, L; Vernillo, R; Vindigni, C, 2012) |
| "Six captive cheetahs (Acinonyx jubatus) with severe gastritis diagnosed by gastric endoscopy and mucosal histopathology were treated with omeprazole, metronidazole, and amoxicillin for 3 wk." | 3.72 | Treatment with omeprazole, metronidazole, and amoxicillin in captive South African cheetahs (Acinonyx jubatus) with spiral bacteria infection and gastritis. ( Burroughs, R; Lane, E; Lobetti, R, 2004) |
| " Given the histology and the fact that rapid urease test results were positive, chronic active gastritis with H." | 3.70 | Iron-deficiency anemia associated with Helicobacter pylori gastritis. ( Imai, T; Konno, M; Muraoka, S; Takahashi, M, 2000) |
| " pylori-infected patients with duodenal ulcer were treated with either omeprazole or famotidine plus two antibiotics for 2 wk." | 3.70 | The long-term reinfection rate and the course of duodenal ulcer disease after eradication of Helicobacter pylori in a developing country. ( Acevedo, C; Duarte, I; Figueroa, C; Fuster, F; Giancaspero, R; Hola, K; Rollan, A; Schulz, M, 2000) |
| "One hundred eight patients with cultured H pylori-positive gastritis or peptic ulcer were treated with three regimens: quadruple treatment without proton pump inhibitors (n = 25), dual treatment with omeprazole and amoxicillin (INN, amoxicilline) (n = 26), and triple treatment with omeprazole, amoxicillin, and clarithromycin (n = 57)." | 3.70 | CYP2C19 genotype-related efficacy of omeprazole for the treatment of infection caused by Helicobacter pylori. ( Aoyama, N; Kasuga, M; Kita, T; Komada, F; Okumura, K; Shirakawa, K; Tanigawara, Y, 1999) |
| " pylori-positive patients with recurrent peptic ulcer diseases, 29 of whom were given triple therapy (amoxycillin and metronidazole for 1 week and plaunotol for 4 weeks)." | 3.69 | Evaluation of a new bismuth-free triple therapy in nude mice and humans. ( Karita, M; Nakazawa, T; Okita, K; Sugiyama, T; Tsuda, M, 1995) |
| "This study describes results of in vitro examination of susceptibility to metronidazole of clinical strains of Helicobacter pylori isolated from patients with gastritis." | 3.69 | [Occurrence of Helicobacter pylori strains resistant to metronidazole]. ( Andrzejewska, E; Jenek, J; Klincewicz, H; Pietkiewicz, K, 1994) |
| " One hundred and thirty two patients with endoscopically confirmed H pylori positive, duodenal ulcer or antral gastritis were treated with triple therapy (colloidal bismuth/metronidazole/amoxicillin) for two weeks." | 3.69 | High Helicobacter pylori numbers are associated with low eradication rate after triple therapy. ( Bujanover, Y; Gilat, T; Hallak, A; Konikoff, FM; Moshkowitz, M; Peled, Y; Santo, M; Tiomny, E, 1995) |
| " pylori-associated gastritis from the gastric tissue following different drug regimens in inoculated nude mice, we evaluated the effectiveness of each regimen, including a new drug, plaunotol." | 3.68 | Evaluation of new therapy for eradication of H. pylori infection in nude mouse model. ( Karita, M; Li, Q; Okita, K, 1993) |
| " Thirty-two consecutive patients (suffering from either peptic ulcer or nonulcer dyspepsia) with Helicobacter pylori infection received omeprazole (40 mg) + bismuth subcitrate (240 mg x 4) + amoxicillin suspension (2000 mg x 4) + metronidazole (500 mg x 4), for only one day." | 3.68 | One-day therapy for treatment of Helicobacter pylori infection. ( Barbara, L; Biasco, G; Corinaldesi, R; Gasperoni, S; Paparo, GF; Ricci-Maccarini, M; Stanghellini, V; Tucci, A; Varoli, O, 1993) |
| " Helicobacter pylori status and the histology of the antral and oxyntic mucosa were evaluated in 25 patients with duodenal ulcer treated with a triple schedule of furazolidone, metronidazole and amoxicillin, and in 16 patients treated only with cimetidine." | 3.68 | Histology of the mucosa of gastric antrum and body before and after eradication of Helicobacter pylori. ( Barbosa, AJ; Castro, LP; Coelho, LG; Lima Júnior, GF; Mendes, EN; Oliveira, CA; Passos, MC; Queiroz, DM; Resende, LM; Rocha, GA, 1993) |
| "Nine patients with Helicobacter pylori-related antral gastritis and history of duodenal ulceration were studied before and at 1 and 7 months after eradication of the infection by a 4-week course of tripotassium dicitrato bismuthate, metronidazole, and amoxycillin." | 3.68 | Plasma gastrin, daytime intragastric pH, and nocturnal acid output before and at 1 and 7 months after eradication of Helicobacter pylori in duodenal ulcer subjects. ( Chittajalu, R; Dahill, SW; el Nujumi, AM; Fullarton, GM; Hilditch, TE; MacDonald, AM; McColl, KE, 1991) |
| "SUMMARY Eradikacion therapy at patients with chronic pancreatitis and combined with Helicobacter associated erosive gastropathy in a month after treatment appeared successful at 75% patients which accepted therapy of the first line--pantoprazol, amoksicillin, klaritromicin." | 2.79 | [Estimation of efficiency of anti-helicobacter therapy in patients with a chronic pancreatitis combined with an erosive gastropathy]. ( Kotsiubniak, LA; Koval', VIu; Moskal', OM, 2014) |
| "Gastritis was assessed according to the updated Sydney classification for activity, chronic inflammation, gastric glandular atrophy, intestinal metaplasia, and H." | 2.74 | Helicobacter pylori eradication in patients on long-term treatment with NSAIDs reduces the severity of gastritis: a randomized controlled trial. ( Bijlsma, JW; Bloemena, E; Boers, M; De Leest, HT; Dijkmans, BA; Houben, HH; Janssen, M; Kostense, PJ; Kuipers, EJ; Lems, WF; Steen, KS; Van de Laar, MA, 2009) |
| " A therapeutical scheme (omeprazole, metronidazole, amoxicilline) obtained a further pathogenetic substantiation of B type CG patient treatment with additional antioxidant vitamin E use at the dosage of 300 mg/day for three weeks." | 2.71 | [Lipid peroxidation and antioxidant system in treatment dynamics of patients with chronic gastritis]. ( Postavnyĭ, VE, 2005) |
| " Sixty-eight patients received 30 mg of lansoprazole once daily, 500 mg of amoxicillin and 250 mg of metronidazole thrice daily for 2 weeks (LAM group), while the other 67 patients received the same dosage of those agents plus 18,000 tyrosine units of pronase thrice daily for 2 weeks (LAMP group)." | 2.70 | Additive effect of pronase on the efficacy of eradication therapy against Helicobacter pylori. ( Akamatsu, T; Gotoh, A; Ikeno, T; Ishida, K; Kaneko, T; Katsuyama, T; Kawakami, Y; Kiyosawa, K; Ota, H; Shimizu, T; Shimodaira, K; Sugiyama, A, 2002) |
| "Helicobacter pylori gastritis is usually a lifelong disease which can cause different topographical inflammatory reactions and induce divergent effects on acid secretion in humans." | 2.70 | Helicobacter pylori and different topographic types of gastritis: treatment response after successful eradication therapy in functional dyspepsia. ( Färkkilä, M; Koskenpato, J; Sipponen, P, 2002) |
| "Metronidazole resistance was found in 44% of pre-treatment cultures of H." | 2.69 | Triple therapy for Helicobacter pylori eradication: a comparison of pantoprazole once versus twice daily. ( Axon, AT; Bardhan, KD; Braun, W; Cooper, BT; Dillon, J; Gatz, G; Tildesley, G; Wyatt, JI, 2000) |
| " The aim of this study was to determine the optimal dose and duration of lansoprazole (LA) administration in combination with amoxicillin (AMPC) and metronidazole (MNZ)." | 2.69 | Eradication of Helicobacter pylori using 30 mg or 60 mg lansoprazole combined with amoxicillin and metronidazole: one and two weeks of a new triple therapy. ( Asaka, M; Ishizuka, J; Kagaya, H; Katagiri, M; Kato, M; Komatsu, Y; Kudo, M; Kudo, T; Nishikawa, K; Sugiyama, T; Sukegawa, M; Takeda, H; Toyota, J, 1999) |
| "pylori-related gastritis, have focused mainly on medium and long-term change following eradication therapies." | 2.69 | Rapid elimination of Helicobacter pylori and reduction of histocompatibility leucocyte antigen-DR expression 12 h after a single dose of omeprazole, amoxycillin and metronidazole triple therapy. ( Chadwick, VS; Chen, W; Shu, D; Tie, A; Wilson, IR, 1999) |
| "Duodenal ulcer recurrence and gastritis are reduced with successful Helicobacter pylori treatment." | 2.67 | Patient factors affecting Helicobacter pylori eradication with triple therapy. ( Cutler, AF; Schubert, TT, 1993) |
| "pylori eradication therapy to prevent gastric cancer." | 2.58 | World trends for H. pylori eradication therapy and gastric cancer prevention strategy by H. pylori test-and-treat. ( Mori, H; Suzuki, H, 2018) |
| "pylori associated diseases such as gastric cancer is expected." | 2.50 | [Expanded indication of National Health Insurance for H. pylori associated gastritis]. ( Kato, M, 2014) |
| " dosing of levofloxacin (81%[95% CI: 78%-89%]vs 84%[95% CI: 66%-97%])." | 2.43 | Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection: a meta-analysis. ( Chey, WD; Kim, HM; Saad, RJ; Schoenfeld, P, 2006) |
| "Emphysematous gastritis is a life-threatening disease." | 2.42 | Emphysematous gastritis and severe aplastic anemia. ( Cantalapiedra, A; Del Villar, R; García-Frade, LJ; Gutierrez, O; Peñarrubia, MJ; Sales, R; Tabuyo, MI, 2003) |
| "Clarithromycin resistance was significantly associated with geographic region (P = 0." | 2.41 | Risk factors for Helicobacter pylori resistance in the United States: the surveillance of H. pylori antimicrobial resistance partnership (SHARP) study, 1993-1999. ( Bhattacharyya, H; Hopkins, RJ; King, EC; Meyer, JM; Morris, D; Siepman, NY; Silliman, NP; Sugg, JE; Wang, W; Zhang, J, 2002) |
| "Eosinophilic gastroenteritis is a rare inflammatory disorder of the gastrointestinal tract." | 1.62 | Eosinophilic gastroenteritis in an adolescent male with history of chronic bullous disease. ( Castor, MAR; Murillo, JML; Recto, MST; Tan-Lim, CSC, 2021) |
| "Emphysematous gastritis is a rare disease caused by gas-forming organisms." | 1.51 | Recognizing emphysematous gastritis. ( Smith, B; Weaver, A; Weintraub, R, 2019) |
| "pylori gastritis were examined from medical centers in four different geographic regions of the USA." | 1.43 | Helicobacter pylori Clarithromycin Resistance and Treatment Failure Are Common in the USA. ( Arnold, CA; Coss, E; Cryer, B; Doern, CD; Dunbar, KB; Lam-Himlin, DM; Mitui, M; Okwara, C; Park, JY; Thung, I; Valasek, MA, 2016) |
| "Emphysematous gastritis is a rare form of gastritis characterized by gaseous dissection of the stomach wall usually secondary to invasion by gas forming organisms, corrosive ingestion, trauma, or gastric infarction." | 1.37 | Emphysematous gastritis associated with ulcerative esophagitis. ( Abbass, K; Akram, S; Hassan, S; Markert, R, 2011) |
| "Clarithromycin resistance was very high even in strains from paediatric patients not previously treated for H." | 1.35 | [High percentage of clarithromycin and metronidazole resistance in Helicobacter pylori clinical isolates obtained from Spanish children]. ( Agudo, S; Alarcón, T; Cibrelus, L; López-Brea, M; Martínez, MJ; Urruzuno, P, 2009) |
| "Chronic gastritis was evaluated according to sydney system." | 1.33 | [Prospective study of 420 biopsies realised in patients with duodenal ulcer with positive Helicobacter pylori]. ( Ben Ayed, M; Ben Khelifa, H; Chedly-Debbiche, A; Gargouri, D; Ghorbel, AJ; Kharrat, J; Khayat, O; Kilani, A; Souissi, A; Zeddini, A, 2006) |
| "Gastric metaplasia was endoscopically and histologically evaluated before and after eradication of this bacterium." | 1.32 | Long-term follow-up of gastric metaplasia after eradication of Helicobacter pylori. ( Sano, T; Urakami, Y, 2003) |
| "Clarithromycin resistance was more common in older patients (P<0." | 1.31 | Factors affecting the variation in antibiotic resistance of Helicobacter pylori over a 3-year period. ( Ducóns, JA; Ferrero, M; Gomollón, F; Santolaria, S; Sicilia, B; Sierra, E, 2000) |
| "Clarithromycin was also transferred with acid but was then rapidly degraded." | 1.31 | Impact of acid secretion, gastritis, and mucus thickness on gastric transfer of antibiotics in rats. ( Atherton, JC; Barrett, DA; Jenkins, D; Jordan, N; Shaw, PN; Sherwood, PV; Spiller, RC; Wibawa, JI, 2002) |
| "Gastritis was scored according to Sydney criteria." | 1.30 | Anti-Helicobacter pylori specific antibody immunohistochemistry improves the diagnostic accuracy of Helicobacter pylori in biopsy specimen from patients treated with triple therapy. ( Angelucci, D; Cellini, L; Di Campli, E; Diodoro, MG; Grossi, L; Marzio, L, 1998) |
| "Lactoferrin (Lf) is an iron-binding glycoprotein present in milk, lacrimae, saliva, and gastroduodenal secretions." | 1.30 | Relation of lactoferrin levels in gastric mucosa with Helicobacter pylori infection and with the degree of gastric inflammation. ( Ikemura, N; Imoto, I; Misaki, M; Nakao, K; Shibata, T; Taguchi, Y; Takaji, S; Yamauchi, K; Yamazaki, N, 1997) |
| "Treatment with amoxicillin, metronidazole, and famotidine may not be effective in eradicating gastric infections with Helicobacter spp in dogs." | 1.30 | Use of a [13C]urea breath test for detection of gastric infection with Helicobacter spp in dogs. ( Cornetta, AM; Gleed, RD; McDonough, PL; Simpson, KW; Strauss-Ayali, D, 1998) |
| "One hundred and thirty patients with proven H pylori infection (by at least two tests) were treated with low dose triple therapy (DeNol 1 qid, tetracycline 250 mg qid and metronidazole 200 mg qid for 2 weeks; dosing with meals and at night); 83 were given a standard prescription for triple therapy (dispensed in bottles) and 47 were given a medication pack with times of dosing clearly marked." | 1.29 | An audit of low dose triple therapy for eradication of Helicobacter pylori. ( Ali, MR; Chua, LE; Fraser, AG; Hollis, B; Little, SV; Moore, L, 1996) |
| "pylori recurrence." | 1.29 | Long-term Helicobacter pylori recurrence after successful eradication with triple therapy. ( Cutler, AF; Schubert, TT, 1993) |
| "Its relationship to gastritis has not been studied." | 1.29 | Gastric mucosal hepatocyte growth factor in Helicobacter pylori gastritis and peptic ulcer disease. ( Beattie, AD; Curry, GW; Morton, R; Park, RH; Taha, AS, 1996) |
| "No recrudescence was observed in group I for 12 months nor for 3 months in group II after eradication." | 1.29 | Natural and experimental Helicobacter mustelae reinfection following successful antimicrobial eradication in ferrets. ( Batchelder, M; Fox, JG; Hayward, A; Murphy, JC; Palley, L; Shames, B; Yan, L, 1996) |
| "A 30-year-old man with AIDS presented with symptoms of fever, epigastric pain and weight loss, together with histological findings of Helicobacter pylori-induced gastritis." | 1.28 | Severe Helicobacter pylori infection in a patient with AIDS. ( Blackwell, N; Khoo, SH, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (3.03) | 18.7374 |
| 1990's | 132 (50.00) | 18.2507 |
| 2000's | 64 (24.24) | 29.6817 |
| 2010's | 52 (19.70) | 24.3611 |
| 2020's | 8 (3.03) | 2.80 |
| Authors | Studies |
|---|---|
| Lai, CH | 2 |
| Rao, YK | 1 |
| Fang, SH | 1 |
| Sing, YT | 2 |
| Tzeng, YM | 1 |
| Chang, CS | 1 |
| Liu, JF | 1 |
| Lin, HJ | 1 |
| Lin, CD | 1 |
| Tang, CH | 1 |
| Lu, DY | 1 |
| Chen, LY | 1 |
| Kao, MC | 1 |
| Kuo, SC | 1 |
| Tseng, YY | 1 |
| Liou, JM | 1 |
| Hsu, TL | 1 |
| Cheng, WC | 1 |
| Wu, MS | 1 |
| Wong, CH | 1 |
| He, C | 1 |
| Kong, F | 2 |
| Zhu, X | 1 |
| Zhao, W | 1 |
| Liu, Y | 1 |
| Wang, K | 1 |
| Vu, TB | 1 |
| Tran, TNQ | 1 |
| Tran, TQA | 1 |
| Vu, DL | 1 |
| Hoang, VT | 1 |
| Arévalo, A | 1 |
| Otero, WA | 1 |
| Trespalacios, AA | 1 |
| Hsu, PI | 1 |
| Tsay, FW | 1 |
| Kao, JY | 1 |
| Peng, NJ | 1 |
| Tsai, KW | 1 |
| Tsai, TJ | 1 |
| Kuo, CH | 2 |
| Kao, SS | 1 |
| Wang, HM | 1 |
| Chen, YH | 2 |
| Shie, CB | 1 |
| Wu, DC | 2 |
| Thieu, H | 1 |
| Bach Dat, B | 1 |
| Nam, NH | 1 |
| Reda, A | 1 |
| Duc, NT | 1 |
| Alshareef, A | 1 |
| Nguyen, JG | 1 |
| Ngoc, NM | 1 |
| Tien Huy, N | 1 |
| Kono, Y | 1 |
| Kusumoto, C | 1 |
| Kiguchi, T | 1 |
| Okada, H | 1 |
| Tang, Y | 1 |
| Tang, G | 1 |
| Pan, L | 1 |
| Zhu, H | 1 |
| Zhou, S | 1 |
| Wei, Z | 1 |
| Tan-Lim, CSC | 1 |
| Murillo, JML | 1 |
| Recto, MST | 1 |
| Castor, MAR | 1 |
| Babakhanlou, R | 1 |
| Larkin, K | 1 |
| Lee, SM | 2 |
| Kim, N | 4 |
| Kwon, YH | 1 |
| Nam, RH | 2 |
| Kim, JM | 2 |
| Park, JY | 2 |
| Lee, YS | 1 |
| Lee, DH | 4 |
| Mahachai, V | 1 |
| Vilaichone, RK | 1 |
| Pittayanon, R | 1 |
| Rojborwonwitaya, J | 1 |
| Leelakusolvong, S | 1 |
| Maneerattanaporn, M | 1 |
| Chotivitayatarakorn, P | 1 |
| Treeprasertsuk, S | 1 |
| Kositchaiwat, C | 1 |
| Pisespongsa, P | 1 |
| Mairiang, P | 1 |
| Rani, A | 2 |
| Leow, A | 1 |
| Mya, SM | 1 |
| Lee, YC | 2 |
| Vannarath, S | 1 |
| Rasachak, B | 1 |
| Chakravuth, O | 1 |
| Aung, MM | 1 |
| Ang, TL | 2 |
| Sollano, JD | 1 |
| Trong Quach, D | 1 |
| Sansak, I | 1 |
| Wiwattanachang, O | 1 |
| Harnsomburana, P | 1 |
| Syam, AF | 1 |
| Yamaoka, Y | 1 |
| Fock, KM | 2 |
| Goh, KL | 2 |
| Sugano, K | 1 |
| Graham, D | 2 |
| Suzuki, H | 2 |
| Mori, H | 1 |
| Agudo-Fernández, S | 1 |
| González Blanco, A | 1 |
| Sue, S | 1 |
| Shibata, W | 1 |
| Sasaki, T | 1 |
| Kaneko, H | 1 |
| Irie, K | 1 |
| Kondo, M | 1 |
| Maeda, S | 1 |
| Manfredi, M | 1 |
| Gaiani, F | 1 |
| Kayali, S | 1 |
| Bizzarri, B | 1 |
| Iuliano, S | 1 |
| Minelli, R | 1 |
| Leandro, G | 4 |
| Di Mario, F | 5 |
| De' Angelis, GL | 1 |
| Weaver, A | 1 |
| Weintraub, R | 1 |
| Smith, B | 1 |
| Lee, JW | 1 |
| Soo In, C | 1 |
| Alfizah, H | 1 |
| Rukman, AH | 1 |
| Norazah, A | 1 |
| Hamizah, R | 1 |
| Ramelah, M | 1 |
| Sierra, F | 1 |
| Forero, JD | 1 |
| Rey, M | 1 |
| Botero, ML | 1 |
| Cárdenas, A | 1 |
| Nishizawa, T | 1 |
| Takahashi, M | 2 |
| Suzuki, M | 1 |
| Hibi, T | 1 |
| Cecchini, MP | 1 |
| Pellegrini, C | 1 |
| Bassetto, MA | 1 |
| Osculati, F | 1 |
| Sbarbati, A | 1 |
| Marcolini, L | 1 |
| Pegoraro, M | 1 |
| Fontana, R | 1 |
| De Franceschi, L | 1 |
| Makobongo, MO | 1 |
| Einck, L | 1 |
| Peek, RM | 1 |
| Merrell, DS | 1 |
| Kim, MS | 1 |
| Kim, SE | 1 |
| Jo, HJ | 1 |
| Shin, CM | 2 |
| Park, YS | 2 |
| Furuta, T | 1 |
| Sugimoto, M | 1 |
| Kodaira, C | 1 |
| Nishino, M | 1 |
| Yamade, M | 1 |
| Uotani, T | 1 |
| Sahara, S | 1 |
| Ichikawa, H | 1 |
| Yamada, T | 1 |
| Osawa, S | 1 |
| Sugimoto, K | 1 |
| Watanabe, H | 1 |
| Umemura, K | 1 |
| Sasaki, H | 1 |
| Nagahara, A | 1 |
| Hojo, M | 1 |
| Asaoka, D | 1 |
| Matsumoto, K | 1 |
| Osada, T | 1 |
| Watanabe, S | 2 |
| Gong, EJ | 1 |
| Yun, SC | 1 |
| Jung, HY | 1 |
| Lim, H | 1 |
| Choi, KS | 1 |
| Ahn, JY | 1 |
| Lee, JH | 1 |
| Kim, DH | 1 |
| Choi, KD | 1 |
| Song, HJ | 1 |
| Lee, GH | 1 |
| Kim, JH | 1 |
| Kato, M | 3 |
| Oh, DH | 1 |
| Kang, KK | 1 |
| Yoon, H | 1 |
| Hwang, JH | 1 |
| Jeoung, SH | 1 |
| Kim, JW | 1 |
| Jang, ES | 1 |
| Jung, HC | 1 |
| Tu, S | 1 |
| Yang, H | 1 |
| Lee, HJ | 1 |
| Kim, JI | 1 |
| Lee, JS | 1 |
| Jun, EJ | 1 |
| Oh, JH | 1 |
| Cheung, DY | 1 |
| Chung, WC | 1 |
| Kim, BW | 3 |
| Kim, SS | 1 |
| Berry, AC | 1 |
| Nakshabendi, R | 1 |
| Baltz, AC | 1 |
| Song, M | 1 |
| Ang, D | 1 |
| Kwek, AB | 1 |
| Ong, J | 1 |
| Tan, J | 1 |
| Teo, EK | 1 |
| Dhamodaran, S | 1 |
| Ben Chaabane, N | 1 |
| Al-Adhba, HS | 1 |
| Koval', VIu | 1 |
| Kotsiubniak, LA | 1 |
| Moskal', OM | 1 |
| Rahmani, A | 1 |
| Abangah, G | 1 |
| Moradkhani, A | 1 |
| Hafezi Ahmadi, MR | 1 |
| Asadollahi, K | 1 |
| Heo, J | 1 |
| Jeon, SW | 1 |
| Jung, JT | 1 |
| Kwon, JG | 1 |
| Lee, DW | 1 |
| Kim, HS | 1 |
| Yang, CH | 1 |
| Park, JB | 1 |
| Park, KS | 1 |
| Cho, KB | 1 |
| Lee, SH | 1 |
| Jang, BI | 1 |
| Kim, JS | 2 |
| Park, SM | 2 |
| Bai, P | 1 |
| Zhou, LY | 2 |
| Xiao, XM | 1 |
| Luo, Y | 1 |
| Ding, Y | 1 |
| Tongtawee, T | 1 |
| Dechsukhum, C | 1 |
| Leeanansaksiri, W | 1 |
| Kaewpitoon, S | 1 |
| Kaewpitoon, N | 1 |
| Loyd, RA | 1 |
| Matrakool, L | 1 |
| Panpimanmas, S | 1 |
| John, A | 1 |
| Al Kaabi, S | 1 |
| Doiphode, S | 1 |
| Chandra, P | 1 |
| Sharma, M | 1 |
| Babu, R | 1 |
| Yacoub, R | 1 |
| Derbala, M | 1 |
| Dunbar, KB | 1 |
| Mitui, M | 1 |
| Arnold, CA | 1 |
| Lam-Himlin, DM | 1 |
| Valasek, MA | 1 |
| Thung, I | 1 |
| Okwara, C | 1 |
| Coss, E | 1 |
| Cryer, B | 1 |
| Doern, CD | 1 |
| Campillo, A | 1 |
| Amorena, E | 1 |
| Ostiz, M | 1 |
| Kutz, M | 1 |
| LaIglesia, M | 1 |
| Okuda, M | 1 |
| Kikuchi, S | 1 |
| Mabe, K | 1 |
| Osaki, T | 1 |
| Kamiya, S | 1 |
| Fukuda, Y | 1 |
| Ji, JS | 1 |
| Choi, H | 1 |
| Al Rasheed, MR | 1 |
| Senseng, CG | 1 |
| De Leest, HT | 1 |
| Steen, KS | 1 |
| Bloemena, E | 1 |
| Lems, WF | 1 |
| Kuipers, EJ | 1 |
| Van de Laar, MA | 1 |
| Bijlsma, JW | 1 |
| Janssen, M | 1 |
| Houben, HH | 1 |
| Kostense, PJ | 1 |
| Boers, M | 1 |
| Dijkmans, BA | 1 |
| Severi, C | 1 |
| Abdullahi, M | 1 |
| Tari, R | 1 |
| Vannella, L | 1 |
| Marcheggiano, A | 1 |
| Capoccia, D | 1 |
| Leonetti, F | 1 |
| Osborn, J | 1 |
| Annibale, B | 2 |
| Bago, J | 1 |
| Pevec, B | 1 |
| Tomić, M | 1 |
| Marusić, M | 1 |
| Bakula, V | 1 |
| Bago, P | 1 |
| Agudo, S | 1 |
| Alarcón, T | 2 |
| Cibrelus, L | 1 |
| Urruzuno, P | 2 |
| Martínez, MJ | 1 |
| López-Brea, M | 3 |
| Kivistö, R | 1 |
| Linros, J | 1 |
| Rossi, M | 1 |
| Rautelin, H | 3 |
| Hänninen, ML | 1 |
| O'connor, A | 1 |
| Taneike, I | 1 |
| Nami, A | 1 |
| Fitzgerald, N | 1 |
| Murphy, P | 1 |
| Ryan, B | 1 |
| O'connor, H | 1 |
| Qasim, A | 1 |
| Breslin, N | 1 |
| O'moráin, C | 3 |
| Koosirirat, C | 1 |
| Linpisarn, S | 1 |
| Changsom, D | 1 |
| Chawansuntati, K | 1 |
| Wipasa, J | 1 |
| Ben Mansour, K | 1 |
| Burucoa, C | 1 |
| Zribi, M | 1 |
| Masmoudi, A | 1 |
| Karoui, S | 1 |
| Kallel, L | 1 |
| Chouaib, S | 1 |
| Matri, S | 1 |
| Fekih, M | 1 |
| Zarrouk, S | 1 |
| Labbene, M | 1 |
| Boubaker, J | 1 |
| Cheikh, I | 1 |
| Hriz, MB | 1 |
| Siala, N | 1 |
| Ayadi, A | 1 |
| Filali, A | 1 |
| Mami, NB | 1 |
| Najjar, T | 1 |
| Maherzi, A | 1 |
| Sfar, MT | 1 |
| Fendri, C | 1 |
| Buonavolontà, R | 1 |
| Miele, E | 1 |
| Russo, D | 1 |
| Vecchione, R | 1 |
| Staiano, A | 1 |
| Schwarzer, A | 1 |
| Iwańczak, B | 1 |
| Martínez-Gómez, MZ | 1 |
| Kalach, N | 1 |
| Roma-Giannikou, E | 1 |
| Liptay, S | 1 |
| Bontem, P | 1 |
| Buderus, S | 1 |
| Wenzl, TG | 1 |
| Koletzko, S | 1 |
| Bugdaci, MS | 1 |
| Zuhur, SS | 1 |
| Sokmen, M | 1 |
| Toksoy, B | 1 |
| Bayraktar, B | 1 |
| Albayrak, B | 1 |
| Altuntas, Y | 1 |
| Tian, XL | 1 |
| Zhang, JZ | 1 |
| Geng, QM | 1 |
| Han, YJ | 1 |
| Hassan, S | 1 |
| Abbass, K | 1 |
| Markert, R | 1 |
| Akram, S | 1 |
| Shcherbakov, PL | 1 |
| Ianova, OB | 1 |
| Belousova, NL | 1 |
| Masharova, AA | 1 |
| Shcherbakova, MIu | 1 |
| Goncharenko, LS | 1 |
| Firsova, LD | 1 |
| Kim, VA | 1 |
| Govorun, VM | 1 |
| Kashnikov, VS | 1 |
| Huang, YK | 1 |
| Wu, MC | 1 |
| Wang, SS | 1 |
| Chang, LL | 1 |
| Wang, TH | 1 |
| Wang, WM | 1 |
| Kuo, FC | 1 |
| Figura, N | 1 |
| Moretti, E | 1 |
| Vaglio, L | 1 |
| Langone, F | 1 |
| Vernillo, R | 1 |
| Vindigni, C | 1 |
| Giordano, N | 1 |
| Koskenpato, J | 1 |
| Färkkilä, M | 1 |
| Sipponen, P | 1 |
| Sherwood, PV | 1 |
| Wibawa, JI | 1 |
| Atherton, JC | 2 |
| Jordan, N | 1 |
| Jenkins, D | 2 |
| Barrett, DA | 1 |
| Shaw, PN | 1 |
| Spiller, RC | 1 |
| Cui, M | 1 |
| Hu, F | 1 |
| Jiang, H | 1 |
| Zheng, X | 1 |
| Olafsson, S | 1 |
| Hatlebakk, JG | 1 |
| Berstad, A | 1 |
| Crone, J | 1 |
| Granditsch, G | 1 |
| Huber, WD | 1 |
| Binder, C | 1 |
| Innerhofer, A | 1 |
| Amann, G | 1 |
| Hirschl, AM | 1 |
| Urakami, Y | 1 |
| Sano, T | 1 |
| Gutierrez, O | 1 |
| Cantalapiedra, A | 1 |
| Tabuyo, MI | 1 |
| Del Villar, R | 1 |
| Peñarrubia, MJ | 1 |
| Sales, R | 1 |
| García-Frade, LJ | 1 |
| van Zanten, SJ | 1 |
| Kolesnikow, T | 1 |
| Leung, V | 1 |
| O'Rourke, JL | 1 |
| Lee, A | 1 |
| Lane, E | 1 |
| Lobetti, R | 1 |
| Burroughs, R | 1 |
| Ozturk, Y | 1 |
| Buyukgebiz, B | 1 |
| Ozer, E | 1 |
| Arslan, N | 1 |
| Bekem, O | 1 |
| Hizli, S | 1 |
| Calvet, X | 1 |
| Montserrat, A | 1 |
| Güell, M | 1 |
| Vergara, M | 1 |
| Gené, E | 1 |
| Schuster, M | 1 |
| Hu, YY | 1 |
| Zhou, ZF | 1 |
| Nan, Q | 1 |
| Jiang, HY | 1 |
| Zhang, L | 1 |
| Li, XY | 1 |
| Duan, LP | 1 |
| Chen, YR | 1 |
| Rodríguez-Torres, M | 1 |
| Salgado-Mercado, R | 1 |
| Ríos-Bedoya, CF | 1 |
| Aponte-Rivera, E | 1 |
| Marxuach-Cuétara, AM | 1 |
| Rodríguez-Orengo, JF | 1 |
| Fernández-Carbia, A | 1 |
| Chen, J | 1 |
| Chen, FB | 1 |
| Yu, JD | 1 |
| Chen, XJ | 1 |
| Li, ZY | 1 |
| Zhang, XP | 1 |
| Francavilla, R | 1 |
| Lionetti, E | 1 |
| Castellaneta, SP | 1 |
| Magistà, AM | 1 |
| Boscarelli, G | 1 |
| Piscitelli, D | 1 |
| Amoruso, A | 1 |
| Di Leo, A | 1 |
| Miniello, VL | 1 |
| Francavilla, A | 1 |
| Cavallo, L | 1 |
| Ierardi, E | 1 |
| Cheng, H | 1 |
| Hu, FL | 1 |
| Matsushima, M | 1 |
| Suzuki, T | 2 |
| Kurumada, T | 1 |
| Watanabe, K | 3 |
| Kobayashi, K | 1 |
| Deguchi, R | 1 |
| Masui, A | 1 |
| Takagi, A | 1 |
| Shirai, T | 1 |
| Muraoka, H | 1 |
| Kobayashi, I | 1 |
| Mine, T | 1 |
| Murakami, K | 2 |
| Sato, R | 2 |
| Okimoto, T | 2 |
| Nasu, M | 1 |
| Fujioka, T | 2 |
| Kodama, M | 2 |
| Abe, T | 1 |
| Sato, S | 1 |
| Arita, T | 1 |
| Onoda, N | 1 |
| Katsuragi, K | 1 |
| Sawada, T | 1 |
| Maeda, K | 1 |
| Mino, A | 1 |
| Ohira, M | 1 |
| Ishikawa, T | 1 |
| Wakasa, K | 1 |
| Hirakawa, K | 1 |
| Postavnyĭ, VE | 1 |
| Saad, RJ | 1 |
| Schoenfeld, P | 1 |
| Kim, HM | 1 |
| Chey, WD | 1 |
| Nista, EC | 1 |
| Candelli, M | 1 |
| Zocco, MA | 1 |
| Cremonini, F | 1 |
| Ojetti, V | 1 |
| Finizio, R | 1 |
| Spada, C | 1 |
| Cammarota, G | 1 |
| Gasbarrini, G | 3 |
| Gasbarrini, A | 2 |
| Ziemniak, W | 1 |
| Khayat, O | 1 |
| Kilani, A | 1 |
| Chedly-Debbiche, A | 1 |
| Zeddini, A | 1 |
| Gargouri, D | 1 |
| Kharrat, J | 1 |
| Souissi, A | 1 |
| Ghorbel, AJ | 1 |
| Ben Ayed, M | 1 |
| Ben Khelifa, H | 1 |
| Kumala, W | 1 |
| Chen, LH | 1 |
| Luo, HS | 1 |
| Prokopova, IV | 1 |
| Makarenko, IuI | 1 |
| Osin, AIa | 1 |
| Ovchar, GV | 1 |
| Kopyt'ko, TA | 1 |
| Labenz, J | 5 |
| Stolte, M | 4 |
| Peitz, U | 3 |
| Tillenburg, B | 3 |
| Köhl, H | 1 |
| Becker, T | 3 |
| Börsch, G | 6 |
| Schepp, W | 1 |
| Blum, AL | 1 |
| Kreiss, C | 1 |
| Armstrong, D | 1 |
| Moshkowitz, M | 2 |
| Konikoff, FM | 2 |
| Peled, Y | 2 |
| Santo, M | 2 |
| Hallak, A | 2 |
| Bujanover, Y | 2 |
| Tiomny, E | 2 |
| Gilat, T | 2 |
| Chong, SK | 1 |
| Lou, Q | 1 |
| Asnicar, MA | 1 |
| Zimmerman, SE | 1 |
| Croffie, JM | 1 |
| Lee, CH | 1 |
| Fitzgerald, JF | 2 |
| Blecker, U | 1 |
| McKeithan, TW | 1 |
| Hart, J | 1 |
| Kirschner, BS | 1 |
| Ozmen, MM | 1 |
| Johnson, CD | 1 |
| Lynch, DA | 1 |
| Mapstone, NP | 1 |
| Clarke, AM | 1 |
| Sobala, GM | 1 |
| Jackson, P | 1 |
| Morrison, L | 1 |
| Dixon, MF | 2 |
| Quirke, P | 1 |
| Axon, AT | 3 |
| Wewer, V | 1 |
| Christiansen, KM | 1 |
| Andersen, LP | 1 |
| Henriksen, FW | 1 |
| Hansen, JP | 1 |
| Tvede, M | 1 |
| Krasilnikoff, PA | 1 |
| Park, KN | 1 |
| Hahm, JS | 1 |
| Kim, HJ | 1 |
| Gormally, SM | 1 |
| Prakash, N | 1 |
| Durnin, MT | 1 |
| Daly, LE | 2 |
| Clyne, M | 1 |
| Kierce, BM | 1 |
| Drumm, B | 3 |
| Adamek, RJ | 2 |
| Opferkuch, W | 2 |
| Wegener, M | 2 |
| tho Pesch, S | 1 |
| Müller, W | 1 |
| Borchard, F | 1 |
| Peters, U | 1 |
| Szymanski, C | 1 |
| Pfaffenbach, B | 1 |
| Ricken, D | 1 |
| Rokkas, T | 1 |
| Papatheodorou, G | 1 |
| Karameris, A | 1 |
| Mavrogeorgis, A | 1 |
| Kalogeropoulos, N | 1 |
| Giannikos, N | 1 |
| Queiroz, DM | 2 |
| Moura, SB | 1 |
| Mendes, EN | 2 |
| Rocha, GA | 2 |
| Barbosa, AJ | 2 |
| de Carvalho, AS | 1 |
| Marshall, BJ | 1 |
| Peh, SC | 1 |
| Parasakthi, N | 1 |
| Wong, NW | 1 |
| Tan, KK | 1 |
| Lo, YL | 1 |
| Andrzejewska, E | 1 |
| Jenek, J | 1 |
| Klincewicz, H | 1 |
| Pietkiewicz, K | 1 |
| Tee, W | 1 |
| Seppälä, K | 2 |
| Kosunen, TU | 2 |
| Learned-Coughlin, S | 1 |
| Solcia, E | 2 |
| Villani, L | 2 |
| Fiocca, R | 2 |
| Luinetti, O | 2 |
| Boldorini, R | 1 |
| Trespi, E | 2 |
| Perego, M | 2 |
| Alvisi, C | 2 |
| Lazzaroni, M | 3 |
| Bianchi Porro, G | 3 |
| Peura, DA | 1 |
| Graham, DY | 2 |
| Wagner, S | 2 |
| Haruma, K | 2 |
| Gladziwa, U | 1 |
| Soudah, B | 2 |
| Gebel, M | 2 |
| Bleck, J | 1 |
| Schmidt, H | 1 |
| Manns, M | 1 |
| Boixeda, D | 2 |
| Tucci, A | 3 |
| Poli, L | 2 |
| Gasperoni, S | 2 |
| Varoli, O | 3 |
| Paparo, GF | 3 |
| De Giorgio, R | 1 |
| Stanghellini, V | 3 |
| Corinaldesi, R | 2 |
| Rebora, A | 1 |
| Drago, F | 1 |
| Picciotto, A | 1 |
| Resende, LM | 1 |
| Coelho, LG | 1 |
| Passos, MC | 1 |
| Castro, LP | 1 |
| Oliveira, CA | 1 |
| Lima Júnior, GF | 1 |
| Ruiz, B | 2 |
| Rood, JC | 1 |
| Fontham, ET | 1 |
| Malcom, GT | 1 |
| Hunter, FM | 2 |
| Sobhan, M | 2 |
| Johnson, WD | 1 |
| Correa, P | 3 |
| Witteman, EM | 1 |
| Hopman, WP | 1 |
| Becx, MC | 2 |
| De Koning, RW | 2 |
| Tytgat, GN | 5 |
| Janssen, AJ | 2 |
| Jansen, JB | 1 |
| Fontham, E | 1 |
| Samloff, IM | 1 |
| Biasco, G | 2 |
| Ricci-Maccarini, M | 1 |
| Barbara, L | 1 |
| Cutler, AF | 2 |
| Schubert, TT | 2 |
| Karita, M | 2 |
| Li, Q | 1 |
| Okita, K | 2 |
| Pavicić, MJ | 1 |
| Namavar, F | 1 |
| Verboom, T | 1 |
| van Winkelhoff, AJ | 1 |
| De Graaff, J | 1 |
| Khulusi, S | 1 |
| Badve, S | 1 |
| Patel, P | 1 |
| Lloyd, R | 1 |
| Marrero, JM | 2 |
| Finlayson, C | 1 |
| Mendall, MA | 1 |
| Northfield, TC | 2 |
| Tsuda, M | 1 |
| Sugiyama, T | 2 |
| Nakazawa, T | 1 |
| Diehl, HG | 1 |
| de Boer, WA | 2 |
| Driessen, WM | 1 |
| Dal Bó, N | 1 |
| Grassi, SA | 1 |
| Rugge, M | 1 |
| Cassaro, M | 1 |
| Donisi, PM | 1 |
| Vianello, F | 1 |
| Kusstatscher, S | 1 |
| Salandin, S | 1 |
| Grasso, GA | 1 |
| Ferrana, M | 1 |
| Battaglia, G | 1 |
| Artan, R | 1 |
| Gelen, T | 1 |
| Bargiggia, S | 2 |
| Maconi, G | 2 |
| Franceschi, M | 4 |
| Cesana, B | 1 |
| Taha, AS | 2 |
| Curry, GW | 1 |
| Morton, R | 2 |
| Park, RH | 2 |
| Beattie, AD | 2 |
| Hentschel, E | 1 |
| Jurgos, L | 1 |
| Duris, I | 1 |
| Bátovský, M | 1 |
| Simkovicová, M | 1 |
| Pauer, M | 1 |
| Dorociak, F | 1 |
| Majercík, M | 1 |
| Kratochvílová, H | 1 |
| Valko, L | 1 |
| Paulen, P | 1 |
| Sangaletti, O | 1 |
| Boldorini, M | 1 |
| Fraser, AG | 1 |
| Moore, L | 1 |
| Ali, MR | 1 |
| Chua, LE | 1 |
| Hollis, B | 1 |
| Little, SV | 1 |
| Cilleruelo Pascual, ML | 1 |
| Urruzuno Tellería, P | 1 |
| Román Riechman, E | 1 |
| Medina Benítez, E | 1 |
| Manzanares López-Manzanares, J | 1 |
| Echávarri Olavarría, F | 1 |
| Molina Arias, M | 1 |
| Goenka, MK | 1 |
| Das, K | 1 |
| Vaiphei, K | 1 |
| Nijhawan, R | 1 |
| Kocbhar, R | 1 |
| Weel, JF | 1 |
| van der Hulst, RW | 3 |
| Gerrits, Y | 1 |
| van der Ende, A | 2 |
| Dankert, J | 1 |
| Beastall, G | 1 |
| Alder, JD | 1 |
| Ewing, PJ | 1 |
| Mitten, MJ | 1 |
| Oleksijew, A | 1 |
| Tanaka, SK | 1 |
| Brill, S | 1 |
| Pilotto, A | 3 |
| Soffiati, G | 2 |
| Scagnelli, M | 2 |
| Bozzola, L | 2 |
| Valerio, G | 2 |
| Gisbert, JP | 1 |
| Redondo, C | 1 |
| Alvarez Baleriola, I | 1 |
| Jiménez, I | 1 |
| Pérez García, JI | 1 |
| Pajares, JM | 1 |
| Bock, H | 1 |
| Mares, A | 1 |
| Wang, XM | 1 |
| Taniguchi, Y | 1 |
| Nishifuku, K | 1 |
| Kidaira, K | 1 |
| Sato, K | 1 |
| Sohara, H | 1 |
| Kawada, H | 1 |
| Kimura, K | 1 |
| Kajiwara, M | 1 |
| Caselli, M | 1 |
| Trevisani, L | 1 |
| Tursi, A | 1 |
| Sartori, S | 1 |
| Ruina, M | 1 |
| Luzzi, I | 1 |
| Gaudenzi, P | 1 |
| Alvisi, V | 1 |
| Dohil, R | 1 |
| Israel, DM | 1 |
| Hassall, E | 1 |
| Jarczyk, G | 1 |
| Jarczyk, J | 1 |
| Raczyńska, A | 1 |
| Jedrzejczyk, W | 1 |
| Adams, RM | 1 |
| Walsh, D | 1 |
| Goggin, N | 1 |
| Rowland, M | 2 |
| Durnin, M | 2 |
| Moriarty, S | 1 |
| Siehoff, S | 1 |
| Nakao, K | 1 |
| Imoto, I | 1 |
| Ikemura, N | 1 |
| Shibata, T | 1 |
| Takaji, S | 1 |
| Taguchi, Y | 1 |
| Misaki, M | 1 |
| Yamauchi, K | 1 |
| Yamazaki, N | 1 |
| Forbes, GM | 1 |
| Marignani, M | 1 |
| Angeletti, S | 1 |
| Bordi, C | 1 |
| Malagnino, F | 1 |
| Mancino, C | 1 |
| Delle Fave, G | 1 |
| Götz, JM | 1 |
| Thio, JL | 1 |
| Verspaget, HW | 1 |
| Offerhaus, GJ | 1 |
| Biemond, I | 1 |
| Lamers, CB | 1 |
| Veenendaal, RA | 1 |
| Vcev, A | 1 |
| Vuković, D | 1 |
| Ivandić, A | 1 |
| Vceva, A | 1 |
| Dmitrović, B | 1 |
| Kovacić, D | 1 |
| Volaric, M | 1 |
| Paulini, D | 1 |
| Mićunović, N | 1 |
| Horvat, D | 1 |
| Mihaljević, S | 1 |
| Popiela, T | 1 |
| Kulig, J | 1 |
| Karcz, D | 1 |
| Tabor, J | 1 |
| Torres, J | 1 |
| Márquez, M | 1 |
| Fillat, O | 1 |
| Herrero, E | 1 |
| Ortiz, JA | 1 |
| Kim, MJ | 1 |
| Michener, R | 1 |
| Triadafilopoulos, G | 1 |
| Tan, WC | 1 |
| Hogan, J | 1 |
| Purkayastha, SK | 1 |
| Lombard, M | 1 |
| Krasner, N | 1 |
| Wack, RF | 1 |
| Eaton, KA | 1 |
| Kramer, LW | 1 |
| Harford, W | 1 |
| Lanza, F | 1 |
| Arora, A | 1 |
| Haber, M | 1 |
| Weissfeld, A | 1 |
| Rose, P | 1 |
| Siepman, N | 1 |
| Mégraud, F | 1 |
| Malfertheiner, P | 2 |
| Lind, T | 1 |
| Veldhuyzen van Zanten, S | 2 |
| Unge, P | 1 |
| Spiller, R | 1 |
| Bayerdörffer, E | 3 |
| Bardhan, KD | 3 |
| Bradette, M | 1 |
| Chiba, N | 1 |
| Wrangstadh, M | 1 |
| Cederberg, C | 1 |
| Idström, JP | 1 |
| Suriani, R | 1 |
| Ravizza, M | 1 |
| Pallante, C | 1 |
| Mazzucco, D | 1 |
| Cardesi, E | 1 |
| Colozza, M | 1 |
| Malandrino, M | 1 |
| Oneglio, R | 1 |
| Orso Giacone, G | 1 |
| Dusio, P | 1 |
| Vajo, M | 1 |
| Keller, JJ | 1 |
| Rauws, EA | 1 |
| Batchelder, M | 1 |
| Fox, JG | 1 |
| Hayward, A | 1 |
| Yan, L | 1 |
| Shames, B | 1 |
| Murphy, JC | 1 |
| Palley, L | 1 |
| Czinn, SJ | 1 |
| Bierman, JC | 1 |
| Diters, RW | 1 |
| Blanchard, TG | 1 |
| Leunk, RD | 1 |
| Ling, TK | 1 |
| Cheng, AF | 1 |
| Sung, JJ | 1 |
| Yiu, PY | 1 |
| Chung, SS | 1 |
| Lambert, I | 1 |
| Gormally, S | 1 |
| Thomas, JE | 1 |
| Hetherington, C | 1 |
| Korman, MG | 2 |
| Bolin, TD | 2 |
| Engelman, JL | 2 |
| Pianko, S | 1 |
| Hunt, RH | 1 |
| Cockeram, A | 1 |
| Schep, G | 1 |
| Malatjalian, D | 1 |
| Sidorov, J | 1 |
| Matisko, A | 1 |
| Jewell, D | 1 |
| Misiewicz, JJ | 1 |
| Harris, AW | 1 |
| Levi, S | 2 |
| Cooper, BT | 2 |
| Kerr, GD | 1 |
| Langworthy, H | 1 |
| Piper, D | 1 |
| Marzio, L | 1 |
| Angelucci, D | 1 |
| Grossi, L | 1 |
| Diodoro, MG | 1 |
| Di Campli, E | 1 |
| Cellini, L | 1 |
| Berquist, WE | 1 |
| Carnicer, J | 1 |
| Grove, DI | 1 |
| Koutsouridis, G | 1 |
| Cummins, AG | 1 |
| Troncone, R | 1 |
| Ellenrieder, V | 2 |
| Fensterer, H | 1 |
| Waurick, M | 1 |
| Adler, G | 2 |
| Glasbrenner, B | 2 |
| Nicholson, FB | 1 |
| Tosetti, C | 1 |
| Grigioni, W | 1 |
| Mazzoni, C | 1 |
| Caletti, G | 1 |
| Stack, WA | 1 |
| Knifton, A | 1 |
| Thirlwell, D | 1 |
| Cockayne, A | 1 |
| Hawkey, CJ | 1 |
| Casswall, TH | 1 |
| Alfvén, G | 1 |
| Drapinski, M | 1 |
| Bergström, M | 1 |
| Dahlström, KA | 1 |
| Cornetta, AM | 1 |
| Simpson, KW | 1 |
| Strauss-Ayali, D | 1 |
| McDonough, PL | 1 |
| Gleed, RD | 1 |
| Konorev, MR | 1 |
| Van der Wouden, EJ | 1 |
| Thijs, JC | 1 |
| Zwet, AA | 1 |
| Kooy, A | 1 |
| Kleibeuker, JH | 1 |
| Chen, W | 1 |
| Shu, D | 1 |
| Wilson, IR | 1 |
| Tie, A | 1 |
| Chadwick, VS | 1 |
| van 't Hoff, BW | 1 |
| Fortunato, A | 1 |
| Rassu, M | 2 |
| Meli, S | 1 |
| Dhali, GK | 1 |
| Garg, PK | 1 |
| Sharma, MP | 1 |
| Tepes, B | 1 |
| Kavcic, B | 1 |
| Zaletel, LK | 1 |
| Gubina, M | 1 |
| Ihan, A | 1 |
| Poljak, M | 1 |
| Krizman, I | 1 |
| Mera, R | 1 |
| Realpe, JL | 1 |
| Bravo, LE | 1 |
| DeLany, JP | 1 |
| Boeck, W | 1 |
| Richter, C | 1 |
| Marre, R | 1 |
| Boyanova, L | 2 |
| Tanigawara, Y | 1 |
| Aoyama, N | 1 |
| Kita, T | 1 |
| Shirakawa, K | 1 |
| Komada, F | 1 |
| Kasuga, M | 1 |
| Okumura, K | 1 |
| Nishikawa, K | 1 |
| Ishizuka, J | 1 |
| Kudo, T | 1 |
| Komatsu, Y | 1 |
| Katagiri, M | 1 |
| Sukegawa, M | 1 |
| Kagaya, H | 1 |
| Kudo, M | 1 |
| Takeda, H | 1 |
| Toyota, J | 1 |
| Asaka, M | 1 |
| García Pérez, A | 1 |
| Valverde de La Osa, J | 1 |
| Giménez Samper, M | 1 |
| Alonso García, I | 1 |
| Dillon, J | 1 |
| Tildesley, G | 1 |
| Wyatt, JI | 1 |
| Gatz, G | 1 |
| Braun, W | 1 |
| Rollan, A | 1 |
| Giancaspero, R | 1 |
| Fuster, F | 1 |
| Acevedo, C | 1 |
| Figueroa, C | 1 |
| Hola, K | 1 |
| Schulz, M | 1 |
| Duarte, I | 1 |
| Hoshi, T | 1 |
| Sasano, H | 1 |
| Kato, K | 2 |
| Ohara, S | 2 |
| Shimosegawa, T | 2 |
| Toyota, T | 1 |
| Nagura, H | 2 |
| Dammann, HG | 1 |
| Fölsch, UR | 1 |
| Hahn, EG | 1 |
| von Kleist, DH | 1 |
| Klör, HU | 1 |
| Kirchner, T | 1 |
| Strobel, S | 1 |
| Kist, M | 1 |
| Shamaly, H | 1 |
| Berkowitz, D | 1 |
| Rosenthal, E | 1 |
| Naveh, Y | 1 |
| van Etten, RJ | 1 |
| Schneeberger, PM | 1 |
| Bojarski, C | 1 |
| Epple, HJ | 1 |
| Kirstein, FW | 1 |
| Fromm, M | 1 |
| Bisson, S | 1 |
| Riecken, EO | 1 |
| Schulzke, JD | 1 |
| Adamsson, I | 1 |
| Edlund, C | 1 |
| Nord, CE | 1 |
| Stancheva, I | 1 |
| Spassova, Z | 1 |
| Katzarov, N | 1 |
| Mitov, I | 1 |
| Koumanova, R | 1 |
| Vukobrat-Bijedić, Z | 1 |
| Lacević, N | 1 |
| Bratović, I | 1 |
| Gribajcević, M | 1 |
| Gogov, B | 1 |
| Radović, S | 1 |
| Konno, M | 1 |
| Muraoka, S | 1 |
| Imai, T | 1 |
| Giannini, E | 1 |
| Romagnoli, P | 1 |
| Fasoli, A | 1 |
| Chiarbonello, B | 1 |
| Malfatti, F | 1 |
| Botta, F | 1 |
| Risso, D | 1 |
| Lantieri, PB | 1 |
| Savarino, V | 1 |
| Testa, R | 1 |
| Miskovitz, P | 1 |
| Cooper, R | 1 |
| Nagler, J | 1 |
| Ferrero, M | 1 |
| Ducóns, JA | 1 |
| Sicilia, B | 1 |
| Santolaria, S | 1 |
| Sierra, E | 1 |
| Gomollón, F | 1 |
| Perri, F | 1 |
| Festa, V | 1 |
| Clemente, R | 1 |
| Villani, MR | 1 |
| Quitadamo, M | 1 |
| Caruso, N | 1 |
| Bergoli, ML | 1 |
| Andriulli, A | 1 |
| Zwolińska-Wcisło, M | 1 |
| Palka, M | 1 |
| Ashorn, M | 1 |
| Ruuska, T | 1 |
| Mäkipernaa, A | 1 |
| Cicconi, V | 1 |
| Carloni, E | 1 |
| Franceschi, F | 1 |
| Nocente, R | 1 |
| Silveri, NG | 1 |
| Manna, R | 1 |
| Servidei, S | 1 |
| Bentivoglio, AR | 1 |
| Müller, H | 1 |
| Rappel, S | 1 |
| Wündisch, T | 2 |
| Tankovic, J | 1 |
| Lamarque, D | 1 |
| Lascols, C | 1 |
| Soussy, CJ | 1 |
| Delchier, JC | 1 |
| Vichev, E | 1 |
| Krŭstev, N | 1 |
| Krŭstev, D | 1 |
| Baeva, N | 1 |
| Kiselova, A | 1 |
| Ianev, N | 1 |
| Toro, C | 1 |
| García-Samaniego, J | 1 |
| Carbó, J | 1 |
| Iñiguez, A | 1 |
| Baquero, M | 1 |
| Alpen, B | 1 |
| Röbbecke, J | 1 |
| Neubauer, A | 1 |
| Meyer, JM | 1 |
| Silliman, NP | 1 |
| Wang, W | 1 |
| Siepman, NY | 1 |
| Sugg, JE | 1 |
| Morris, D | 1 |
| Zhang, J | 1 |
| Bhattacharyya, H | 1 |
| King, EC | 1 |
| Hopkins, RJ | 1 |
| Treiber, G | 1 |
| Wittig, J | 1 |
| Ammon, S | 1 |
| Walker, S | 1 |
| van Doorn, LJ | 1 |
| Klotz, U | 1 |
| Schilling, D | 1 |
| Messerer, P | 1 |
| Ott, MG | 1 |
| Schauwecker, P | 1 |
| Zober, A | 1 |
| Riemann, JF | 1 |
| Fujimura, S | 1 |
| Kato, S | 1 |
| Kawamura, T | 1 |
| Watanabe, A | 1 |
| Isomoto, H | 1 |
| Kohno, S | 1 |
| Noguchi, K | 1 |
| Sekine, H | 1 |
| Gotoh, A | 1 |
| Akamatsu, T | 1 |
| Shimizu, T | 1 |
| Shimodaira, K | 1 |
| Kaneko, T | 1 |
| Kiyosawa, K | 1 |
| Ishida, K | 1 |
| Ikeno, T | 1 |
| Sugiyama, A | 1 |
| Kawakami, Y | 1 |
| Ota, H | 1 |
| Katsuyama, T | 1 |
| Knippig, C | 1 |
| Arand, F | 1 |
| Leodolter, A | 1 |
| Nilius, M | 1 |
| Klein, U | 1 |
| Sinev, IuV | 1 |
| Gavrilenko, IaV | 1 |
| Vodalagin, VD | 1 |
| Kirillov, VA | 1 |
| Kiselev, IuV | 1 |
| Adeyemi, EO | 1 |
| Fadlalla, H | 1 |
| al-Homsi, M | 1 |
| Nnalue, NA | 1 |
| Goodwin, S | 1 |
| Boehme, D | 1 |
| Sim, AJ | 1 |
| Goggin, PM | 1 |
| Spychal, RT | 1 |
| Jackson, PA | 1 |
| Corbishley, CM | 1 |
| Yahav, J | 1 |
| Oderda, G | 1 |
| Diver-Haber, A | 1 |
| Keller, N | 1 |
| Jonas, A | 1 |
| Dobrilla, G | 1 |
| Piazzi, L | 1 |
| Amplatz, S | 1 |
| Benvenuti, S | 1 |
| Di Fede, F | 1 |
| Smoot, DT | 1 |
| Scott, VF | 1 |
| Vaara, M | 1 |
| Renkonen, OV | 1 |
| Heatley, RV | 1 |
| Lew, GM | 1 |
| Malaty, HM | 1 |
| Evans, DG | 1 |
| Evans, DJ | 1 |
| Klein, PD | 1 |
| Alpert, LC | 1 |
| Genta, RM | 1 |
| Lukash, NV | 1 |
| Kriuchkova, ON | 1 |
| Gofel'd, AM | 1 |
| Varrentrapp, M | 1 |
| Lange, P | 1 |
| Müller, MJ | 1 |
| Schorn, T | 1 |
| Bär, W | 1 |
| Khoo, SH | 1 |
| Blackwell, N | 1 |
| Martín, E | 1 |
| López-Lavid, C | 1 |
| Sanz, JC | 1 |
| McColl, KE | 1 |
| Fullarton, GM | 1 |
| Chittajalu, R | 1 |
| el Nujumi, AM | 1 |
| MacDonald, AM | 1 |
| Dahill, SW | 1 |
| Hilditch, TE | 1 |
| Lind, CD | 1 |
| Blaser, MJ | 1 |
| Clasener, HA | 1 |
| Talley, NJ | 1 |
| Ormand, JE | 1 |
| Carpenter, HA | 1 |
| Phillips, SF | 1 |
| Uppal, R | 1 |
| Lateef, SK | 1 |
| Korsten, MA | 1 |
| Paronetto, F | 1 |
| Lieber, CS | 1 |
| Xiao, SD | 1 |
| Liu, WZ | 1 |
| Xia, DH | 1 |
| Jiang, SJ | 1 |
| Wang, RN | 1 |
| Zhang, ZH | 1 |
| Xu, WW | 1 |
| Beardshall, K | 1 |
| Swift, I | 1 |
| Foulkes, W | 1 |
| Playford, R | 1 |
| Ghosh, P | 1 |
| Calam, J | 1 |
| Chaĭka, NA | 1 |
| Elta, GH | 1 |
| Murphy, R | 1 |
| Behler, EM | 1 |
| Barnett, JL | 1 |
| Nostrant, TT | 1 |
| Kern, S | 1 |
| Appelman, H | 1 |
| Rühl, GH | 1 |
| McNulty, CA | 1 |
| Dent, J | 1 |
| Wise, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Comparison of Vonoprazan and Amoxicillin Dual Therapy With Standard Triple Therapy With Proton Pump Inhibitor for Helicobacter Pylori Eradication; a Randomized Control Trial[NCT04901663] | Phase 4 | 179 participants (Actual) | Interventional | 2021-06-21 | Completed | ||
| The Effect of Different Time Intervals on Rescue Treatment of Helicobacter Pylori Infection: a Prospective, Multicenter Observational Study[NCT05620589] | 626 participants (Anticipated) | Observational | 2022-11-11 | Not yet recruiting | |||
| The Effect of Different Time Intervals on Rescue Treatment of Helicobacter Pylori Infection: a Prospective, Multicenter Observational Study[NCT05620602] | 628 participants (Anticipated) | Observational | 2022-11-11 | Not yet recruiting | |||
| [NCT01792700] | Phase 4 | 648 participants (Actual) | Interventional | 2003-01-31 | Completed | ||
| Comparing the Efficacy and Impact on Gastrointestinal Microbiome of Reverse Hybrid Therapy and Bismuth Quadruple Therapy in Helicobacter Pylori Eradication[NCT02547038] | 352 participants (Actual) | Interventional | 2015-02-28 | Completed | |||
| Evaluation of the Efficacy of Concomitant Therapy for Eradication of Helicobacter Pylori[NCT01922765] | Phase 4 | 540 participants (Anticipated) | Interventional | 2013-08-31 | Recruiting | ||
| A Randomized Controlled Trial of Triple Therapy Versus Sequential Therapy Versus Concomitant Therapy as First Line Treatment for Helicobacter Pylori Infection[NCT02092506] | Phase 4 | 462 participants (Actual) | Interventional | 2011-12-31 | Completed | ||
| Comparison Between Hybrid, Reverse Hybrid, and Non-Bismuth Levofloxacin Quadruple Regimens for Helicobacter Pylori Infection in Egypt: A Randomized Controlled Trial[NCT04039412] | Phase 4 | 330 participants (Actual) | Interventional | 2018-06-01 | Completed | ||
| Bismuth Quadruple Therapy in Helicobacter Pylori Rescue Therapy: A Multicenter Randomized Non-Inferiority Trial of Different Tetracycline Doses and Frequencies.[NCT05802888] | Phase 4 | 260 participants (Anticipated) | Interventional | 2023-03-12 | Recruiting | ||
| Bismuth-containing Quadruple Therapy for Helicobacter Pylori First-line Treatment: A Multicenter Randomized Clinical Trial of Different Tetracycline Doses and Frequencies.[NCT05431075] | Phase 4 | 407 participants (Anticipated) | Interventional | 2022-07-31 | Not yet recruiting | ||
| Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Therapy: A Multicenter Randomized Non-Inferiority Trial of Different Tetracycline Doses and Frequencies.[NCT05432115] | Phase 4 | 407 participants (Anticipated) | Interventional | 2022-06-25 | Recruiting | ||
| Phase 4, Prospective, Randomized and Comparative Study Comparing Sequential and Concomitant Therapy for Helicobacter Pylori Eradication in Routine Clinical Practice[NCT01273441] | Phase 4 | 338 participants (Actual) | Interventional | 2010-12-31 | Completed | ||
| Sequential Versus Concomitant Therapy for Helicobacter Pylori Infection[NCT00656968] | Phase 4 | 232 participants (Actual) | Interventional | 2007-05-31 | Completed | ||
| A Prospective Randomized Trial of Levofloxacin-amoxicillin Triple Therapy vs. Levofloxacin-tetracycline Quadruple Therapy in Second-line Helicobacter Pylori Treatment[NCT02978157] | 102 participants (Actual) | Interventional | 2015-02-28 | Completed | |||
| Comparison of Two Rescue Therapies for Helicobacter Pylori Infection - A Multicenter Randomized Controlled Trial[NCT02547012] | 51 participants (Actual) | Interventional | 2013-11-30 | Completed | |||
| Personalized Treatment for Refractory H Pylori Infection[NCT02547025] | 126 participants (Actual) | Interventional | 2012-08-01 | Completed | |||
| Comparison of Clinical Outcomes in Bloodstream Infections With Carbapenem Hetero-resistant vs Carbapenem Resistant Klebsiella Pneumoniae (COMBAT)[NCT04229498] | 300 participants (Anticipated) | Observational | 2020-04-30 | Not yet recruiting | |||
| Effectiveness of Rifabutin Triple Therapy for First-line and Rescue Treatment of Helicobacter Pylori Infection[NCT04652284] | Phase 3 | 300 participants (Anticipated) | Interventional | 2021-05-01 | Not yet recruiting | ||
| Efficacy and Safety of Black Seed Oil With Vonoprazan Based Triple Therapy in Treatment of Helicobacter Pylori[NCT05957432] | Phase 2 | 90 participants (Anticipated) | Interventional | 2023-07-15 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Evaluate eradication outcome by endoscopy urease test and histology or urea breath test (Number of Participants With Complete Eradication of Helicobacter Pylori) (NCT02547038)
Timeframe: sixth week after the end of anti- H. pylori therapy
| Intervention | participants (Number) |
|---|---|
| Pantoprazole+Bismuth+Tetra+Metro | 169 |
| (Panto+Amox+Clar+Metr)+(Panto+Amox) | 170 |
Questionnaire to measure the number of Participants with Treatment-Emergent Adverse Events (NCT04039412)
Timeframe: 10-14 days
| Intervention | Participants (Count of Participants) |
|---|---|
| (1) Reverse Hybrid Regimen | 49 |
| (2) Hybrid Regimen | 58 |
| (3) Levofloxacin Quadruple Regimen | 44 |
Measuring the curative rate of each regimen by a fecal antigen test (NCT04039412)
Timeframe: 40-44 days
| Intervention | Participants (Count of Participants) |
|---|---|
| (1) Reverse Hybrid Regimen | 102 |
| (2) Hybrid Regimen | 101 |
| (3) Levofloxacin Quadruple Regimen | 91 |
Questionnaire to evaluate the compliance with each treatment regimen (NCT04039412)
Timeframe: 10-14 days
| Intervention | Participants (Count of Participants) |
|---|---|
| (1) Reverse Hybrid Regimen | 109 |
| (2) Hybrid Regimen | 107 |
| (3) Levofloxacin Quadruple Regimen | 108 |
Evaluate eradication outcome by endoscopy urease test and histology or urea breath test (NCT00656968)
Timeframe: one month after finishing study drugs
| Intervention | participants (Number) |
|---|---|
| Concomitant Therapy (A) | 92 |
| Sequential Therapy (B) | 95 |
Good drug compliance is defined as taking equal to or more than 80% of eradication medicines (NCT00656968)
Timeframe: one month after finishing test therapy
| Intervention | participants (Number) |
|---|---|
| Concomitant Therapy (A) | 106 |
| Sequential Therapy (B) | 104 |
Number of participants with negative H pylori status in follow-up tests as a measure of successful eradication (NCT02978157)
Timeframe: six weeks after the end of anti-H pylori therapy.
| Intervention | participants (Number) |
|---|---|
| Esomeprazole+Amox+Levo | 36 |
| Esomeprazole+Bismuth+Tetra+Levo | 49 |
Evaluate eradication outcome by endoscopy urease test and histology or urea breath test (NCT02547012)
Timeframe: six weeks after the end of anti-H pylori therapy.
| Intervention | participants (Number) |
|---|---|
| Esomeprazole+Amox+Levo+Tetra | 13 |
| Esomeprazole+Amox+Levo | 21 |
25 reviews available for metronidazole and Gastritis
| Article | Year |
|---|---|
Gastrointestinal: Rapid emergence of double-expressor lymphoma after Helicobacter pylori eradication therapy.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Endoscopy, Digestive System; Follow-Up Studies; Gastric Mu | 2021 |
Helicobacter pylori management in ASEAN: The Bangkok consensus report.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Consensus; Drug Resistance, Bacterial; | 2018 |
World trends for H. pylori eradication therapy and gastric cancer prevention strategy by H. pylori test-and-treat.
Topics: Anti-Bacterial Agents; Clarithromycin; Consensus; Disease Eradication; Drug Resistance, Bacterial; G | 2018 |
Meta-analysis of first-line triple therapy for helicobacter pylori eradication in Korea: is it time to change?
Topics: Alkylating Agents; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Communicab | 2014 |
[Expanded indication of National Health Insurance for H. pylori associated gastritis].
Topics: Amoxicillin; Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Gast | 2014 |
Sequential or concomitant therapy for eradication of Helicobacter pylori infection: A systematic review and meta-analysis.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Databases, Bibliographic; Drug Therapy, Combinat | 2015 |
Sarcina ventriculi : Review of the Literature.
Topics: Anti-Infective Agents; Clostridium Infections; Diagnosis, Differential; Drug Therapy, Combination; E | 2016 |
Emphysematous gastritis and severe aplastic anemia.
Topics: Anemia, Aplastic; Antilymphocyte Serum; Cholelithiasis; Cyclosporine; Emphysema; Female; Gastritis; | 2003 |
[Helicobacter pylori: reasons for eradication].
Topics: Adenocarcinoma; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Gastritis | 2004 |
Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection: a meta-analysis.
Topics: Amoxicillin; Anti-Ulcer Agents; Bismuth; Drug Resistance, Bacterial; Drug Therapy, Combination; Gast | 2006 |
Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection: a meta-analysis.
Topics: Amoxicillin; Anti-Ulcer Agents; Bismuth; Drug Resistance, Bacterial; Drug Therapy, Combination; Gast | 2006 |
Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection: a meta-analysis.
Topics: Amoxicillin; Anti-Ulcer Agents; Bismuth; Drug Resistance, Bacterial; Drug Therapy, Combination; Gast | 2006 |
Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection: a meta-analysis.
Topics: Amoxicillin; Anti-Ulcer Agents; Bismuth; Drug Resistance, Bacterial; Drug Therapy, Combination; Gast | 2006 |
Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection: a meta-analysis.
Topics: Amoxicillin; Anti-Ulcer Agents; Bismuth; Drug Resistance, Bacterial; Drug Therapy, Combination; Gast | 2006 |
Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection: a meta-analysis.
Topics: Amoxicillin; Anti-Ulcer Agents; Bismuth; Drug Resistance, Bacterial; Drug Therapy, Combination; Gast | 2006 |
Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection: a meta-analysis.
Topics: Amoxicillin; Anti-Ulcer Agents; Bismuth; Drug Resistance, Bacterial; Drug Therapy, Combination; Gast | 2006 |
Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection: a meta-analysis.
Topics: Amoxicillin; Anti-Ulcer Agents; Bismuth; Drug Resistance, Bacterial; Drug Therapy, Combination; Gast | 2006 |
Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection: a meta-analysis.
Topics: Amoxicillin; Anti-Ulcer Agents; Bismuth; Drug Resistance, Bacterial; Drug Therapy, Combination; Gast | 2006 |
[Functional dyspepsia: approaches to Helicobacter pylori eradication therapy].
Topics: Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Dyspepsia; Gastritis | 1995 |
[Management of the peptic ulcer patient in the Helicobacter pylori age].
Topics: Algorithms; Antacids; Anti-Bacterial Agents; Biopsy; Bismuth; Breath Tests; Child; Drug Therapy, Com | 1994 |
The role of acid inhibition in the treatment of Helicobacter pylori infection.
Topics: Amoxicillin; Depression, Chemical; Drug Administration Schedule; Drug Therapy, Combination; Gastric | 1994 |
Helicobacter pylori: consensus reached: peptic ulcer is on the way to becoming an historic disease.
Topics: Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobac | 1994 |
[Treatment of Helicobacter pylori infection in adults].
Topics: Antacids; Anti-Bacterial Agents; Bismuth; Drug Resistance, Microbial; Drug Therapy, Combination; Gas | 1994 |
Review: Helicobacter pylori. Current issues and new directions.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Bismuth; Drug Therapy, Combination; | 1997 |
Treatment of Helicobacter pylori infection: a review of the world literature.
Topics: Amoxicillin; Antacids; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Resistance, Micro | 1996 |
[Treatment of Helicobacter pylori infections].
Topics: Clarithromycin; Clinical Protocols; Drug Resistance; Drug Therapy, Combination; Duodenal Ulcer; Fema | 1999 |
Microbial ecology and treatment of Helicobacter pylori infections: review.
Topics: Adenocarcinoma; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; | 2000 |
Risk factors for Helicobacter pylori resistance in the United States: the surveillance of H. pylori antimicrobial resistance partnership (SHARP) study, 1993-1999.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarith | 2002 |
[Helicobacter heilmannii-associated gastritis].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Animals; Clarithromycin; Drug Therapy, Combina | 2002 |
Helicobacter pylori and gastric ulcer therapy: reflections and uncertainties.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Cefixime; Cefotaxime; Cimetidine; Drug Therapy, Combinatio | 1992 |
Review article: the treatment of Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Gastritis; Hel | 1992 |
Helicobacter pylori and duodenal ulceration.
Topics: Cimetidine; Duodenal Ulcer; Gastrins; Gastritis; Helicobacter Infections; Helicobacter pylori; Human | 1991 |
[Campylobacter-induced gastritis].
Topics: Antibodies, Bacterial; Campylobacter; Campylobacter Infections; Furazolidone; Gastritis; Humans; Met | 1989 |
92 trials available for metronidazole and Gastritis
| Article | Year |
|---|---|
Equivalent efficacies of reverse hybrid and concomitant therapies in first-line treatment of Helicobacter pylori infection.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Dexlansoprazole; Drug Administratio | 2020 |
Randomized trial of vonoprazan-based versus proton-pump inhibitor-based third-line triple therapy with sitafloxacin for Helicobacter pylori.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Esomeprazole; F | 2019 |
Long-term follow up Helicobacter Pylori reinfection rate after second-line treatment: bismuth-containing quadruple therapy versus moxifloxacin-based triple therapy.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aza Compounds; Breath Tests; Disease-Fr | 2013 |
Sitafloxacin-based third-line rescue regimens for Helicobacter pylori infection in Japan.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cyto | 2014 |
Efficacy of hybrid therapy as first-line regimen for Helicobacter pylori infection compared with sequential therapy.
Topics: Aged; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Gastritis; | 2014 |
Concomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Therapy, Combina | 2015 |
Ten-day triple therapy versus sequential therapy versus concomitant therapy as first-line treatment for Helicobacter pylori infection.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Gastr | 2015 |
Ciprofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: A randomized trial.
Topics: Adolescent; Adult; Aged; Amoxicillin; Ciprofloxacin; Clarithromycin; Drug Therapy, Combination; Fema | 2015 |
[Estimation of efficiency of anti-helicobacter therapy in patients with a chronic pancreatitis combined with an erosive gastropathy].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Th | 2014 |
Coenzyme Q10 in combination with triple therapy regimens ameliorates oxidative stress and lipid peroxidation in chronic gastritis associated with H. pylori infection.
Topics: Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Antioxidants; Double-Blind Method; Drug Therapy, Com | 2015 |
Concomitant and hybrid therapy for Helicobacter pylori infection: A randomized clinical trial.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Esomeprazole; F | 2015 |
Effect of Pretreatment with Lactobacillus delbrueckii and Streptococcus thermophillus on Tailored Triple Therapy for Helicobacter pylori Eradication: A Prospective Randomized Controlled Clinical Trial.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combinati | 2015 |
Randomized clinical trial comparing 10- or 14-day sequential therapy and 10- or 14-day concomitant therapy for the first line empirical treatment of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Clarithromycin; Drug Administration Sche | 2017 |
Helicobacter pylori eradication in patients on long-term treatment with NSAIDs reduces the severity of gastritis: a randomized controlled trial.
Topics: Aged; Amoxicillin; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents | 2009 |
High efficacy of bismuth subcitrate for Helicobacter pylori eradication in pangastritis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Infective Agents | 2009 |
Second-line treatment for Helicobacter pylori infection based on moxifloxacin triple therapy: a randomized controlled trial.
Topics: Adult; Anti-Infective Agents; Anti-Ulcer Agents; Aza Compounds; Breath Tests; Drug Administration Sc | 2009 |
Investigation of the anti-inflammatory effect of Curcuma longa in Helicobacter pylori-infected patients.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Bacterial Load; | 2010 |
Helicobacter pylori chronic gastritis in children: to eradicate or not to eradicate?
Topics: Adolescent; Aluminum Hydroxide; Amoxicillin; Antacids; Anti-Bacterial Agents; Breath Tests; Child; C | 2011 |
New effective treatment regimen for children infected with a double-resistant Helicobacter pylori strain.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Child, Preschool; Drug Res | 2011 |
The role of Helicobacter pylori in patients with hypothyroidism in whom could not be achieved normal thyrotropin levels despite treatment with high doses of thyroxine.
Topics: Adult; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infec | 2011 |
[Enterofuril eradication therapy in chronic inflammatory diseases of the upper digestive tract].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Infective Agents; Chronic Disease; Clarithromyc | 2011 |
Lansoprazole-based sequential and concomitant therapy for the first-line Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infec | 2012 |
Helicobacter pylori and different topographic types of gastritis: treatment response after successful eradication therapy in functional dyspepsia.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Breath Tests; Chronic Disease; Drug T | 2002 |
[Comparison of pantoprazole and omeprazole-based triple therapy regimens in the treatment of Helicobacter pylori infection].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Anti | 2002 |
Patients with endoscopic gastritis and/or duodenitis improve markedly following eradication of Helicobacter pylori, although less so than patients with ulcers.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Duodenitis; Female; Fo | 2002 |
Ranitidine-bismuth citrate, tetracycline and metronidazole followed by triple therapy as alternative strategy for Helicobacter pylori treatment: a pilot study.
Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Bismuth; Clarithromycin; Drug Administration Schedu | 2004 |
Ranitidine-bismuth citrate, tetracycline and metronidazole followed by triple therapy as alternative strategy for Helicobacter pylori treatment: a pilot study.
Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Bismuth; Clarithromycin; Drug Administration Schedu | 2004 |
Ranitidine-bismuth citrate, tetracycline and metronidazole followed by triple therapy as alternative strategy for Helicobacter pylori treatment: a pilot study.
Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Bismuth; Clarithromycin; Drug Administration Schedu | 2004 |
Ranitidine-bismuth citrate, tetracycline and metronidazole followed by triple therapy as alternative strategy for Helicobacter pylori treatment: a pilot study.
Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Bismuth; Clarithromycin; Drug Administration Schedu | 2004 |
Ranitidine-bismuth citrate, tetracycline and metronidazole followed by triple therapy as alternative strategy for Helicobacter pylori treatment: a pilot study.
Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Bismuth; Clarithromycin; Drug Administration Schedu | 2004 |
Ranitidine-bismuth citrate, tetracycline and metronidazole followed by triple therapy as alternative strategy for Helicobacter pylori treatment: a pilot study.
Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Bismuth; Clarithromycin; Drug Administration Schedu | 2004 |
Ranitidine-bismuth citrate, tetracycline and metronidazole followed by triple therapy as alternative strategy for Helicobacter pylori treatment: a pilot study.
Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Bismuth; Clarithromycin; Drug Administration Schedu | 2004 |
Ranitidine-bismuth citrate, tetracycline and metronidazole followed by triple therapy as alternative strategy for Helicobacter pylori treatment: a pilot study.
Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Bismuth; Clarithromycin; Drug Administration Schedu | 2004 |
Ranitidine-bismuth citrate, tetracycline and metronidazole followed by triple therapy as alternative strategy for Helicobacter pylori treatment: a pilot study.
Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Bismuth; Clarithromycin; Drug Administration Schedu | 2004 |
High eradication rates of Helicobacter pylori infection with first- and second-line combination of esomeprazole, tetracycline, and metronidazole in patients allergic to penicillin.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Drug Hypersensitivity; Drug Therapy | 2005 |
Improved efficacy of 10-Day sequential treatment for Helicobacter pylori eradication in children: a randomized trial.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Antitrichomonal | 2005 |
Improved efficacy of 10-Day sequential treatment for Helicobacter pylori eradication in children: a randomized trial.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Antitrichomonal | 2005 |
Improved efficacy of 10-Day sequential treatment for Helicobacter pylori eradication in children: a randomized trial.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Antitrichomonal | 2005 |
Improved efficacy of 10-Day sequential treatment for Helicobacter pylori eradication in children: a randomized trial.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Antitrichomonal | 2005 |
Effectiveness of minocycline-based triple therapy for eradication of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benz | 2006 |
[Lipid peroxidation and antioxidant system in treatment dynamics of patients with chronic gastritis].
Topics: Adult; Aged; alpha-Tocopherol; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Antioxidants; | 2005 |
Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Biopsy; Clarithromycin; Drug Therapy, Combination; E | 2006 |
Efficacy of Helicobacter pylori eradication taking into account its resistance to antibiotics.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; An | 2006 |
Effects of H pylori therapy on erythrocytic and iron parameters in iron deficiency anemia patients with H pylori-positive chronic gastristis.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anemia, Iron-Deficiency; Anti-Infective Agents; Chronic Diseas | 2007 |
Evaluation of three different proton pump inhibitors with amoxicillin and metronidazole in retreatment for Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Infective Agents; Drug Therapy, Co | 2008 |
Omeprazole/amoxicillin versus triple therapy for Helicobacter pylori in duodenal ulcer disease: two-year follow-up of a prospective randomized study.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Duodenal Ulcer; Female; | 1995 |
[Short-term triple therapy with pantoprazole, clarithromycin and metronidazole in eradication of Helicobacter pylori].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Benzimid | 1995 |
Is short-term triple therapy with lansoprazole, clarithromycin, and metronidazole a definitive answer for Helicobacter pylori eradication?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combinatio | 1995 |
Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Double-Blind Method; Drug Therapy, Com | 1994 |
Association of symptoms with Helicobacter pylori infection in children.
Topics: Adolescent; Biopsy; Bismuth; Child; Chronic Disease; Drug Therapy, Combination; Duodenal Ulcer; Duod | 1995 |
Modified short-term triple therapy--ranitidine, clarithromycin, and metronidazole--for cure of Helicobacter pylori infection.
Topics: Adult; Aged; Clarithromycin; Drug Therapy, Combination; Duodenitis; Female; Gastritis; Helicobacter | 1995 |
[Short-term triple therapy with pantoprazole, clarithromycin and metronidazole for the healing of Helicobacter pylori infection].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Benzimidazoles; Biopsy; Clarithrom | 1995 |
Omeprazole 40 mg o.m. combined with amoxycillin alone or with amoxycillin and metronidazole in the eradication of Helicobacter pylori.
Topics: Adult; Aged; Amoxicillin; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; | 1994 |
Effects of eradication of Helicobacter pylori on gastritis in duodenal ulcer patients.
Topics: Amoxicillin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Gastric Mucosa; Gastrit | 1994 |
Evaluation of two therapeutic regimens for the treatment of Helicobacter pylori infection.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Bismuth; Drug Administration Schedule; Drug Therapy, Combinat | 1994 |
Patient factors affecting Helicobacter pylori eradication with triple therapy.
Topics: Adult; Age Factors; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer | 1993 |
Pathogenesis of gastric metaplasia of the human duodenum: role of Helicobacter pylori, gastric acid, and ulceration.
Topics: Adult; Aged; Amoxicillin; Antacids; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Du | 1996 |
Omeprazole coupled with two antibiotics for Helicobacter pylori eradication and prevention of ulcer recurrence.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Double-Blind Method; Drug Therapy, Com | 1996 |
Eradication of Helicobacter pylori and long-term outcome of functional dyspepsia. A clinical endoscopic study.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; | 1996 |
Helicobacter pylori eradication--evaluation of triple therapy containing omeprazole.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ul | 1996 |
One week triple therapy with omeprazole, clarithromycin and tinidazole for Helicobacter pylori: differing efficacy in previously treated and untreated patients.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Clarithromycin; Drug Admin | 1996 |
Cure of Helicobacter pylori infection in the elderly: effects of eradication on gastritis and serological markers.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer | 1996 |
Short-term low-dose triple therapy with azithromycin, metronidazole and lansoprazole appears highly effective for the eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Aged; Anti-Bacterial Agents; A | 1997 |
One week treatment for Helicobacter pylori infection.
Topics: Adolescent; Anti-Bacterial Agents; Antitrichomonal Agents; Bismuth; Breath Tests; Child; Child, Pres | 1997 |
Another therapeutic schedule in eradication of Helicobacter pylori.
Topics: Adult; Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti | 1997 |
Efficacy of ebrotidine and ranitidine combined with amoxicillin and metronidazole in the eradication of Helicobacter pylori in patients with duodenal ulcer.
Topics: Adult; Amoxicillin; Benzenesulfonates; Double-Blind Method; Duodenal Ulcer; Female; Gastritis; Helic | 1997 |
Helicobacter pylori eradication--comparison of three drug regimens and symptomatic assessment in duodenitis and antral gastritis.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; | 1997 |
Double-blind, multicenter evaluation of lansoprazole and amoxicillin dual therapy for the cure of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Diar | 1996 |
Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study.
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Administration Schedule; D | 1996 |
Helicobacter pylori-positive duodenal ulcer: a long-term double-blind randomized study in patients healed with H2-receptor antagonists.
Topics: Adult; Aged; Antacids; Anti-Ulcer Agents; Disease-Free Survival; Double-Blind Method; Doxycycline; D | 1996 |
Carbon 13-labeled urea breath test for the diagnosis of Helicobacter pylori infection in children.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Biopsy; Breath Tests; Carbon Radioisotopes; Child; C | 1997 |
Sucralfate as an alternative to bismuth in quadruple therapy for Helicobacter pylori eradication.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Female; Gastritis; Helicobacter Infe | 1997 |
Adding once-daily omeprazole 20 mg to metronidazole/amoxicillin treatment for Helicobacter pylori gastritis: a randomized, double-blind trial showing the importance of metronidazole resistance.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Chronic Disease; C | 1998 |
One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study Group.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Age | 1997 |
Influence of clarithromycin dosage on pantoprazole combined triple therapy for eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti | 1998 |
Lansoprazole quadruple therapy is effective in curing Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti | 1998 |
Reversal of fundic atrophy after eradication of Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Atrophy; Female; Follow-Up Studies; Gastric A | 1998 |
Safety and efficacy of rabeprazole in combination with four antibiotic regimens for the eradication of Helicobacter pylori in patients with chronic gastritis with or without peptic ulceration.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles; Clarithromy | 1998 |
The influence of metronidazole resistance on the efficacy of ranitidine bismuth citrate triple therapy regimens for Helicobacter pylori infection.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistan | 1999 |
Rapid elimination of Helicobacter pylori and reduction of histocompatibility leucocyte antigen-DR expression 12 h after a single dose of omeprazole, amoxycillin and metronidazole triple therapy.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Drug Therapy, Combination; Female; Ga | 1999 |
Efficacy of 7 day lansoprazole-based triple therapy for Helicobacter pylori infection in elderly patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Amoxicillin; Antibodies, Bacterial | 1999 |
Role of anti-Helicobacter pylori treatment in H. pylori-positive and cytoprotective drugs in H. pylori-negative, non-ulcer dyspepsia: results of a randomized, double-blind, controlled trial in Asian Indians.
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Double-Blind Method; Drug Therapy, Combinat | 1999 |
Eradication of Helicobacter pylori infection with proton pump-based triple therapy in patients in whom bismuth-based triple therapy failed.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; C | 1999 |
Prevalence of resistance to clarithromycin and its clinical impact on the efficacy of Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial | 1999 |
Eradication of Helicobacter pylori using 30 mg or 60 mg lansoprazole combined with amoxicillin and metronidazole: one and two weeks of a new triple therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer | 1999 |
Triple therapy for Helicobacter pylori eradication: a comparison of pantoprazole once versus twice daily.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidaz | 2000 |
Eradication of H. pylori with pantoprazole, clarithromycin, and metronidazole in duodenal ulcer patients: a head-to-head comparison between two regimens of different duration.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Adult; Aged; Anti-Bacterial Agents; Anti-Ul | 2000 |
Efficacy of bismuth-based triple therapy in children with abdominal pain and Helicobacter pylori gastritis.
Topics: Abdominal Pain; Adolescent; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Child, Preschool | 2000 |
Patients with dyspepsia benefit from eradication of Helicobacter pylori if other organic causes for dyspepsia were carefully ruled out.
Topics: Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Bismuth; Clarithromycin; Diagnosis, Differential; Dose- | 2000 |
[Effect of pantoprazole, amoxicillin and metronidazole treatment on the level of H. pylori eradication and the histological image of antral gastritis in patients with duodenal ulcer].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agent | 2000 |
Influence of Helicobacter pylori eradication therapy on 13C aminopyrine breath test: comparison among omeprazole-, lansoprazole-, or pantoprazole-containing regimens.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aminopyrine; Anti-Ulcer Agents; Benzimidazoles | 2000 |
Randomized study of two "rescue" therapies for Helicobacter pylori-infected patients after failure of standard triple therapies.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Benzimidaz | 2001 |
Prevalence of Helicobacter pylori resistance to antibiotics in Northeast Italy: a multicentre study. GISU. Interdisciplinary Group for the Study of Ulcer.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Biopsy, Needle; Clarithromycin; Confidence Interval | 2000 |
Helicobacter pylori and iron deficiency anaemia in children.
Topics: Adolescent; Amoxicillin; Anemia, Iron-Deficiency; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath T | 2001 |
Helicobacter pylori eradication therapy in gastric high grade non Hodgkin's lymphoma (NHL).
Topics: Aged; Anti-Ulcer Agents; Clarithromycin; Combined Modality Therapy; Drug Therapy, Combination; Gastr | 2001 |
Clinical outcome and influencing factors of a new short-term quadruple therapy for Helicobacter pylori eradication: a randomized controlled trial (MACLOR study).
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer | 2002 |
Additive effect of pronase on the efficacy of eradication therapy against Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents | 2002 |
Surface hydrophobicity of gastric mucosa in Helicobacter pylori infection: effect of clearance and eradication.
Topics: Adult; Aged; Amoxicillin; Analysis of Variance; Bismuth; Duodenal Ulcer; Endoscopy, Digestive System | 1992 |
Helicobacter pylori and gastric ulcer therapy: reflections and uncertainties.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Cefixime; Cefotaxime; Cimetidine; Drug Therapy, Combinatio | 1992 |
The role of omeprazole (40 mg) in the treatment of gastric Helicobacter pylori infection.
Topics: Adult; Aged; Amoxicillin; Bismuth; Dose-Response Relationship, Drug; Drug Administration Schedule; F | 1991 |
Triple therapy for Helicobacter pylori in nonulcer dyspepsia.
Topics: Adult; Amoxicillin; Drug Therapy, Combination; Dyspepsia; Female; Gastritis; Helicobacter Infections | 1991 |
Chronic alcoholic gastritis. Roles of alcohol and Helicobacter pylori.
Topics: Adult; Alcoholism; Aluminum Hydroxide; Amoxicillin; Bismuth; Gastritis; Helicobacter Infections; Hel | 1991 |
The efficacy of furazolidone and metronidazole in the treatment of chronic gastritis associated with Helicobacter (Campylobacter) pylori--a randomized double-blind placebo-controlled clinical trial.
Topics: Adolescent; Adult; Aged; Chronic Disease; Double-Blind Method; Female; Furazolidone; Gastric Mucosa; | 1990 |
148 other studies available for metronidazole and Gastritis
| Article | Year |
|---|---|
Identification of 3',4',5'-trimethoxychalcone analogues as potent inhibitors of Helicobacter pylori-induced inflammation in human gastric epithelial cells.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Cell Line; Chalcones; Epithelial Cells; Gastritis; | 2010 |
Synthesis and bioevaluation of novel 3,4,5-trimethoxybenzylbenzimidazole derivatives that inhibit Helicobacter pylori-induced pathogenesis in human gastric epithelial cells.
Topics: Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Proteins; Benzimidazoles; Cell Adhesion; Cell | 2012 |
Development of bacterial transglycosylase inhibitors as new antibiotics: moenomycin A treatment for drug-resistant Helicobacter pylori.
Topics: Anti-Bacterial Agents; Bambermycins; Drug Design; Drug Resistance, Multiple, Bacterial; Duodenal Ulc | 2014 |
Clinical Effect of Clarithromycin Combined with Tinidazole on Helicobacter pylori-Related Gastritis and Its Influence on COX-2 Expression.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Cyclooxygenase 2; Drug Therapy, Combinati | 2021 |
Antibiotic Resistance of
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Cross-Sectional Studies; Drug | 2022 |
Helicobacter pylori: Multiple resistance in patients from Bogotá, Colombia
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Biopsy; Clarithromycin; Colombia; DNA, Bacterial; D | 2019 |
Antibiotic resistance of Helicobacter pylori infection in a children's hospital in Vietnam: prevalence and associated factors.
Topics: Amoxicillin; Child; Child, Preschool; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Comb | 2020 |
Clinical factors associated with initial Helicobacter pylori eradication therapy: a retrospective study in China.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Dr | 2020 |
Eosinophilic gastroenteritis in an adolescent male with history of chronic bullous disease.
Topics: Abdominal Pain; Adolescent; Anti-Infective Agents; Appendicitis; Diarrhea; Enteritis; Eosinophilia; | 2021 |
The value of Metronidazole in the management of acute radiation proctitis.
Topics: Gastritis; Humans; Metronidazole; Proctitis; Radiation Injuries | 2021 |
rdxA, frxA, and efflux pump in metronidazole-resistant Helicobacter pylori: Their relation to clinical outcomes.
Topics: Adult; Aged; Bacterial Proteins; Drug Resistance, Bacterial; Female; Gastritis; Helicobacter Infecti | 2018 |
Retrospective analysis of the use of quadruple therapy with bismuth (Pylera
Topics: Adult; Aged; Breath Tests; Cross-Sectional Studies; Drug Evaluation; Drug Therapy, Combination; Fema | 2018 |
How and when investigating and treating Helicobacter pylori infection in children.
Topics: Amoxicillin; Anti-Bacterial Agents; Biopsy; Child; Child, Preschool; Clarithromycin; Drug Resistance | 2018 |
Recognizing emphysematous gastritis.
Topics: Administration, Intravenous; Aged; Emphysema; Gastritis; Humans; Levofloxacin; Male; Metronidazole; | 2019 |
Risk factors of rescue bismuth quadruple therapy failure for Helicobacter pylori eradication.
Topics: Anti-Bacterial Agents; Bismuth; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Drug T | 2019 |
Risk factors of rescue bismuth quadruple therapy failure for Helicobacter pylori eradication.
Topics: Anti-Bacterial Agents; Bismuth; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Drug T | 2019 |
Risk factors of rescue bismuth quadruple therapy failure for Helicobacter pylori eradication.
Topics: Anti-Bacterial Agents; Bismuth; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Drug T | 2019 |
Risk factors of rescue bismuth quadruple therapy failure for Helicobacter pylori eradication.
Topics: Anti-Bacterial Agents; Bismuth; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Drug T | 2019 |
Ethnicity association of Helicobacter pylori virulence genotype and metronidazole susceptibility.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Asian People; Bacterial Proteins; | 2013 |
Pilot study: miscellaneous therapy is highly successful for Helicobacter pylori eradication.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Gastri | 2013 |
Delay of second-line eradication therapy for Helicobacter pylori can increase eradication failure.
Topics: Aged; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infect | 2013 |
Might Helicobacter pylori infection be associated with distortion on taste perception?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Clarithromycin; Dysgeusia; Female; G | 2013 |
In vitro characterization of the anti-bacterial activity of SQ109 against Helicobacter pylori.
Topics: Adamantane; Amoxicillin; Antitubercular Agents; Cell Membrane; Chloramphenicol; Clarithromycin; Drug | 2013 |
Ten-year trend of the cumulative Helicobacter pylori eradication rate for the 'Japanese eradication strategy'.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Dise | 2013 |
[Progress in the treatment of Helicobacter pylori infection].
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Drugs, Chinese Herbal; Gastritis; | 2014 |
Not All Helicobacter Are pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Anti-Bacterial Agents; Biopsy; Clarithromycin; | 2015 |
Susceptibility of Helicobacter pylori to antibiotics in Chinese patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Cephalosporins; Clarithromycin; Drug Resistance, Bacterial; Drug | 2015 |
Does emerging Clarithromycin resistance signal an obituary to empirical standard triple therapy for Helicobacter pylori infection?
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combin | 2015 |
Helicobacter pylori Clarithromycin Resistance and Treatment Failure Are Common in the USA.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; C | 2016 |
[10-day triple therapy with esomeprazole 40 mg/12 h vs. quadruple concomitant non-bismuth therapy as first line treatment for Helicobacter pylori infection].
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug | 2016 |
Nationwide survey of Helicobacter pylori treatment for children and adolescents in Japan.
Topics: Adolescent; Amoxicillin; Anemia, Iron-Deficiency; Anti-Bacterial Agents; Child; Clarithromycin; Drug | 2017 |
[High percentage of clarithromycin and metronidazole resistance in Helicobacter pylori clinical isolates obtained from Spanish children].
Topics: Adolescent; Amoxicillin; Child; Child, Preschool; Ciprofloxacin; Clarithromycin; Drug Resistance, Mi | 2009 |
Characterization of multiple Helicobacter bizzozeronii isolates from a Finnish patient with severe dyspeptic symptoms and chronic active gastritis.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacteriological Techniques; Catalase; Culture Media; DNA, | 2010 |
Helicobacter pylori resistance to metronidazole and clarithromycin in Ireland.
Topics: Adult; Anti-Bacterial Agents; Biopsy; Clarithromycin; Drug Resistance, Bacterial; Female; Gastritis; | 2010 |
Primary resistance to clarithromycin, metronidazole and amoxicillin of Helicobacter pylori isolated from Tunisian patients with peptic ulcers and gastritis: a prospective multicentre study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Child; Child, Presch | 2010 |
[The effects of pronase on drugs concentrations for treatment of Helicobacter pylori infection in gastric tissue].
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Gastric Mucosa; Gastritis; Helicobac | 2011 |
Emphysematous gastritis associated with ulcerative esophagitis.
Topics: Aged; Anti-Bacterial Agents; Bacterial Infections; Ciprofloxacin; Diabetes Mellitus, Type 2; Emphyse | 2011 |
Factors modulating the outcome of treatment for the eradication of Helicobacter pylori infection.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Antibodies, Bacterial; Antigens, Bacterial; Bacterial P | 2012 |
Impact of acid secretion, gastritis, and mucus thickness on gastric transfer of antibiotics in rats.
Topics: Amoxicillin; Animals; Anti-Infective Agents, Local; Clarithromycin; Gastric Acid; Gastric Mucosa; Ga | 2002 |
Helicobacter pylori in children and adolescents: increase of primary clarithromycin resistance, 1997-2000.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Child; Child, Preschool; Clarithromycin; Drug Resist | 2003 |
Long-term follow-up of gastric metaplasia after eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Cicatrix; Convalescence; Drug The | 2003 |
Gastric transitional zones, areas where Helicobacter treatment fails: results of a treatment trial using the Sydney strain mouse model.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Disease Models, Anim | 2003 |
Treatment with omeprazole, metronidazole, and amoxicillin in captive South African cheetahs (Acinonyx jubatus) with spiral bacteria infection and gastritis.
Topics: Acinonyx; Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; | 2004 |
Resolution of Helicobacter pylori associated granulomatous gastritis in a child after eradication therapy.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Drug Therapy, Combi | 2004 |
[Study on metronidazole resistance to Helicobacter pylori from three populations with different ethnics in Yunnan].
Topics: Adult; China; Chronic Disease; Drug Resistance, Bacterial; Female; Gastritis; Helicobacter Infection | 2004 |
[Prevalence of Helicobacter pylori resistant to clarithromycin, amoxicillin and metronidazole in children].
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Child; Child, Preschool; Clarithromycin; Drug Resist | 2004 |
[The epidemiology of Helicobacter pylori resistance to antibiotics in Beijing].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; China; Clarithromyci | 2005 |
Tetracycline, metronidazole and amoxicillin-metronidazole combinations in proton pump inhibitor-based triple therapies are equally effective as alternative therapies against Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; He | 2006 |
Efficacy of Helicobacter pylori eradication on the chronic mucosal inflammation of the remnant stomach after distal gastrectomy for early gastric cancer.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Infective Agents; Anti-Ulcer | 2005 |
[Prospective study of 420 biopsies realised in patients with duodenal ulcer with positive Helicobacter pylori].
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Biopsy; D | 2006 |
Patterns of Helicobacter pylori isolate resistance to fluoroquinolones, amoxicillin, clarithromycin and metronidazoles.
Topics: Amoxicillin; Anti-Bacterial Agents; Biopsy; Chronic Disease; Clarithromycin; Disk Diffusion Antimicr | 2006 |
[Use of metronidazole in chronic atrophic gastritis in children].
Topics: Atrophy; Chronic Disease; Gastric Mucosa; Gastritis; Humans; Metronidazole | 1980 |
[Omeprazole + clarithromycin + metronidazole--a new standard for eradication of Helicobacter pylori].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin | 1995 |
High Helicobacter pylori numbers are associated with low eradication rate after triple therapy.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Chronic Disease; Colony Count, | 1995 |
Helicobacter pylori infection in recurrent abdominal pain in childhood: comparison of diagnostic tests and therapy.
Topics: Abdominal Pain; Adolescent; Amoxicillin; Antibodies, Bacterial; Bismuth; Child; Child, Preschool; Du | 1995 |
Resolution of Helicobacter pylori-associated gastric lymphoproliferative disease in a child.
Topics: Adolescent; Amoxicillin; Bismuth; Chronic Disease; Drug Therapy, Combination; Female; Follow-Up Stud | 1995 |
Cell proliferation in Helicobacter pylori associated gastritis and the effect of eradication therapy.
Topics: Adult; Cell Division; Chronic Disease; Drug Therapy, Combination; Gastric Mucosa; Gastritis; Helicob | 1995 |
Helicobacter pylori infection in children with recurrent abdominal pain.
Topics: Abdominal Pain; Adolescent; Anti-Ulcer Agents; Biopsy; Child; Child, Preschool; Endoscopy, Gastroint | 1994 |
[Low malignancy MALT lymphoma of the stomach: H. pyloric eradication as a therapeutic concept?].
Topics: Amoxicillin; Drug Therapy, Combination; Follow-Up Studies; Gastric Mucosa; Gastritis; Helicobacter I | 1994 |
Helicobacter pylori infection and gastric juice vitamin C levels. Impact of eradication.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Ascorbic Acid; Bismuth; Drug Therapy, Combination; Female | 1995 |
Effect of Helicobacter pylori eradication on G-cell and D-cell density in children.
Topics: Adolescent; Amoxicillin; Cell Count; Child; Drug Therapy, Combination; Female; Furazolidone; Gastrin | 1994 |
[Occurrence of Helicobacter pylori strains resistant to metronidazole].
Topics: Adult; Aged; Bacterial Typing Techniques; Drug Resistance, Microbial; Female; Gastritis; Helicobacte | 1994 |
Ribotyping patterns and emergence of metronidazole resistance in paired clinical samples of Helicobacter pylori.
Topics: Amoxicillin; Anti-Ulcer Agents; DNA, Bacterial; DNA, Ribosomal; Drug Resistance, Microbial; Drug The | 1994 |
Peripheral neuropathy induced by metronidazole.
Topics: Aged; Aged, 80 and over; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metr | 1994 |
Helicobacter pylori infection and serum pepsinogen A, pepsinogen C, and gastrin in gastritis and peptic ulcer: significance of inflammation and effect of bacterial eradication.
Topics: Amoxicillin; Bismuth; Drug Therapy, Combination; Female; Gastrins; Gastritis; Helicobacter Infection | 1994 |
Helicobacter pylori in patients with rosacea.
Topics: Antibodies, Bacterial; Duodenitis; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; | 1994 |
Histology of the mucosa of gastric antrum and body before and after eradication of Helicobacter pylori.
Topics: Adult; Amoxicillin; Drug Therapy, Combination; Duodenal Ulcer; Female; Furazolidone; Gastric Mucosa; | 1993 |
Vitamin C concentration in gastric juice before and after anti-Helicobacter pylori treatment.
Topics: Amoxicillin; Ascorbic Acid; Bismuth; Female; Gastric Juice; Gastritis; Helicobacter Infections; Heli | 1994 |
Short report: smoking habits and the acquisition of metronidazole resistance in patients with Helicobacter pylori-related gastritis.
Topics: Adult; Aged; Drug Resistance, Microbial; Female; Gastritis; Helicobacter Infections; Helicobacter py | 1993 |
Serum pepsinogens as markers of response to therapy for Helicobacter pylori gastritis.
Topics: Adult; Biopsy; Bismuth; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pyl | 1993 |
One-day therapy for treatment of Helicobacter pylori infection.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Chronic Disease; Drug Administration Schedule; Drug Therapy, | 1993 |
Long-term Helicobacter pylori recurrence after successful eradication with triple therapy.
Topics: Bismuth; Drug Therapy, Combination; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; H | 1993 |
Evaluation of new therapy for eradication of H. pylori infection in nude mouse model.
Topics: Amoxicillin; Animals; Anti-Ulcer Agents; Diterpenes; Drug Evaluation, Preclinical; Drug Therapy, Com | 1993 |
In vitro susceptibility of Helicobacter pylori to several antimicrobial combinations.
Topics: Amoxicillin; Anti-Bacterial Agents; Drug Combinations; Drug Synergism; Gastritis; Helicobacter Infec | 1993 |
Evaluation of a new bismuth-free triple therapy in nude mice and humans.
Topics: Amoxicillin; Animals; Anti-Ulcer Agents; Antitrichomonal Agents; Bismuth; Colony Count, Microbial; C | 1995 |
[One week triple therapy for eradication of Helicobacter pylori infection: simple and effective].
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Adm | 1995 |
Resolution of gastric outlet obstruction after eradication of Helicobacter pylori.
Topics: Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Female; G | 1995 |
Azithromycin for the cure of Helicobacter pylori infection.
Topics: Adult; Aged; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Azithromycin; Drug Therapy, Combina | 1996 |
One-day combined therapy of children with Helicobacter pylori-associated peptic disease.
Topics: Adolescent; Amoxicillin; Anti-Ulcer Agents; Child; Child, Preschool; Drug Administration Schedule; D | 1996 |
Gastric mucosal hepatocyte growth factor in Helicobacter pylori gastritis and peptic ulcer disease.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Biopsy; Drug Therapy, Combination; Female; Gastric Mucosa; Ga | 1996 |
[Comment on the Stolte/Domschke letter-discussion].
Topics: Amoxicillin; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Hum | 1996 |
[Triple combination antimicrobial therapy of Helicobacter pylori and basal levels of serum gastrin].
Topics: Adult; Amoxicillin; Drug Therapy, Combination; Female; Gastrins; Gastritis; Helicobacter Infections; | 1996 |
An audit of low dose triple therapy for eradication of Helicobacter pylori.
Topics: Adult; Aged; Anti-Bacterial Agents; Antitrichomonal Agents; Drug Therapy, Combination; Female; Gastr | 1996 |
[Triple-therapy treatment during 1 month versus 2 weeks in gastroduodenal disease due to Helicobacter pylori in children].
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Bismuth; Child; Child, Preschool; Drug Evaluation; D | 1996 |
Heterogeneity in susceptibility to metronidazole among Helicobacter pylori isolates from patients with gastritis or peptic ulcer disease.
Topics: Drug Resistance, Microbial; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metroni | 1996 |
Insulin-like growth factor-I in Helicobacter pylori gastritis and response to eradication using bismuth based triple therapy.
Topics: Adult; Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Case-Control Studies; Drug Therapy, Co | 1996 |
Relevance of the ferret model of Helicobacter-induced gastritis to evaluation of antibacterial therapies.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Disease Models, Anim | 1996 |
[Breath test in the diagnosis of Helicobacter pylori infection: concordance with histological methods and correlation with anatomopathological lesions of the gastric mucosa].
Topics: Adult; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Breath Tests; Drug T | 1996 |
[Good results with Helicobacter pylori eradication for treatment of non-ulcer dyspepsia].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; D | 1996 |
[Time course of disappearance of Helicobacter pylori after topical therapy and new triple therapy].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Anti-Bacterial Agents; Clarithromycin | 1997 |
Effective 2-wk therapy for Helicobacter pylori disease in children.
Topics: Adolescent; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Clarithromycin; Drug Evaluation; Drug T | 1997 |
[Helicobacter pylori eradication: finally clarity].
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Gastritis; Helicobacter I | 1996 |
[Early results of treating Helicobacter pylori infections in patients with gastric ulcer and gastritis].
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Drug Administration Schedule; Dr | 1996 |
Chronic abdominal pain and Helicobacter pylori.
Topics: Abdominal Pain; Adolescent; Anti-Bacterial Agents; Chronic Disease; Gastric Mucosa; Gastritis; Gastr | 1997 |
[Helicobacter pylori: pretherapeutic resistance status in Germany (Ruhr area)].
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Multiple; Female; Gastritis; Ge | 1997 |
Relation of lactoferrin levels in gastric mucosa with Helicobacter pylori infection and with the degree of gastric inflammation.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Ammonia; Anti-Bacterial Agents; Anti-Ulcer Agents; Biomarke | 1997 |
Reversal of long-standing iron deficiency anaemia after eradication of Helicobacter pylori infection.
Topics: Adult; Anemia, Iron-Deficiency; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; D | 1997 |
Treatment of Helicobacter pylori infection favourably affects gastric mucosal superoxide dismutases.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Clarithromycin; Drug | 1997 |
Serum 13C-bicarbonate assay for the diagnosis of gastric Helicobacter pylori infection and response to treatment.
Topics: Amoxicillin; Bicarbonates; Bismuth; Carbon Isotopes; Clarithromycin; Drug Therapy, Combination; Gast | 1997 |
Treatment of gastritis in cheetahs (Acinonyx jubatus).
Topics: Acinonyx; Animals; Anti-Bacterial Agents; Antitrichomonal Agents; Biopsy; Bismuth; Dose-Response Rel | 1997 |
Treatment of Helicobacter pylori infection: summary of a meeting at the Fourth United European Gastroenterology Week, September 20, 1995.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Antacids; Bismuth; Clarithromycin; Drug Resist | 1996 |
Natural and experimental Helicobacter mustelae reinfection following successful antimicrobial eradication in ferrets.
Topics: Amoxicillin; Animals; Antacids; Bacterial Proteins; Biopsy; Bismuth; DNA, Bacterial; Drug Therapy, C | 1996 |
Characterization and therapy for experimental infection by Helicobacter mustelae in ferrets.
Topics: Amoxicillin; Animals; Antacids; Antibodies, Bacterial; Bismuth; Drug Therapy, Combination; Female; F | 1996 |
An increase in Helicobacter pylori strains resistant to metronidazole: a five-year study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ampicillin; Antacids; Anti-Bacterial Agents; Bismuth; DN | 1996 |
Anti-Helicobacter pylori specific antibody immunohistochemistry improves the diagnostic accuracy of Helicobacter pylori in biopsy specimen from patients treated with triple therapy.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antibodies, Bacterial; Biopsy; D | 1998 |
New, improved Helicobacter pylori eradication therapy in children.
Topics: Adolescent; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Clarithromycin; Drug Therapy, Combinati | 1998 |
[Helicobacter pylori infection and recurrent abdominal pain in children. A proved relationship?].
Topics: Abdominal Pain; Adolescent; Adult; Age Factors; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-U | 1998 |
Comparison of culture, histopathology and urease testing for the diagnosis of Helicobacter pylori gastritis and susceptibility to amoxycillin, clarithromycin, metronidazole and tetracycline.
Topics: Amoxicillin; Anti-Bacterial Agents; Antitrichomonal Agents; Biopsy; Clarithromycin; Gastritis; Helic | 1998 |
Clinical quiz. Gastrospirillum hominis.
Topics: Bacterial Infections; Bismuth; Child; Gastric Mucosa; Gastritis; Helicobacter heilmannii; Humans; Ma | 1998 |
One-week treatment with omeprazole, clarithromycin, and metronidazole in children with Helicobacter pylori infection.
Topics: Adolescent; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; H | 1998 |
Use of a [13C]urea breath test for detection of gastric infection with Helicobacter spp in dogs.
Topics: Amoxicillin; Animals; Anti-Infective Agents; Anti-Ulcer Agents; Biopsy; Breath Tests; Carbon Isotope | 1998 |
Effect of ranitidine and metronidazole on 1gG activity of patients with Helicobacter pylori infection.
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Antibodies, Bacterial; Antibodies, Catalytic; Gastr | 1998 |
Two- to four-year histological follow-up of gastric mucosa after Helicobacter pylori eradication.
Topics: Adult; Aged; Amoxicillin; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Gast | 1999 |
Comparative evaluation of two methods for testing metronidazole susceptibility of Helicobacter pylori in routine practice.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Child; Child, Preschool; Drug Resistance, Microbial; | 1999 |
CYP2C19 genotype-related efficacy of omeprazole for the treatment of infection caused by Helicobacter pylori.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Bism | 1999 |
[Resolution of an autoimmune thrombocytopenic purpura after eradicating treatment of Helicobacter pylori].
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Autoimmune Diseases; Bismuth; Drug Therapy, Combination; Fema | 1999 |
The long-term reinfection rate and the course of duodenal ulcer disease after eradication of Helicobacter pylori in a developing country.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Chile; Developing Countries; Drug Therapy, | 2000 |
Cell damage and proliferation in human gastric mucosa infected by Helicobacter pylori--a comparison before and after H pylori eradication in non-atrophic gastritis.
Topics: Anti-Bacterial Agents; Biopsy; Cell Division; Clarithromycin; DNA Damage; Gastric Mucosa; Gastritis; | 1999 |
A single drug for Helicobacter pylori infection: first results with a new bismuth triple monocapsule.
Topics: Adult; Aged; Anti-Ulcer Agents; Capsules; Female; Gastritis; Gastroscopy; Helicobacter Infections; H | 2000 |
Primary and combined resistance to four antimicrobial agents in Helicobacter pylori in Sofia, Bulgaria.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bulgaria; Child; Child, Preschool; Chronic Disease; | 2000 |
Iron-deficiency anemia associated with Helicobacter pylori gastritis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Anemia, Iron-Deficiency; Anti-Bacterial Agents; | 2000 |
Single drug therapy for Helicobacter pylori infection.
Topics: Bismuth; Capsules; Drug Combinations; Gastritis; Helicobacter Infections; Helicobacter pylori; Human | 2000 |
Factors affecting the variation in antibiotic resistance of Helicobacter pylori over a 3-year period.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarith | 2000 |
[Principles of managing Helicobacter pylori infections. Guidelines of the European Society of Gastroenterology in Primary Health Care].
Topics: Amoxicillin; Biopsy; Clarithromycin; Drug Resistance, Microbial; Duodenoscopy; Enzyme-Linked Immunos | 2000 |
Disappearance of antiphospholipid antibodies syndrome after Helicobacter pylori eradication.
Topics: Adult; Antiphospholipid Syndrome; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Heli | 2001 |
Healing of active, non-atrophic autoimmune gastritis by H. pylori eradication.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Autoimmune Diseases; Clarithromycin; | 2001 |
Clarithromycin resistance of Helicobacter pylori has a major impact on the efficacy of the omeprazole-amoxicillin-clarithromycin therapy.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Biopsy; Clarithromycin; DNA, Bacterial; Dru | 2001 |
[Gastroduodenitis and ulcers--statistical study for 1998].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Bulgaria; Clarithromycin; Drug Ther | 2000 |
[Prevalence of primary Helicobacter pylori resistance to eight antimicrobial agents in a hospital in Madrid].
Topics: Adult; Aged; Amoxicillin; Azithromycin; Cefotaxime; Ciprofloxacin; Clarithromycin; Clindamycin; Cros | 2001 |
Summaries for patients. Factors associated with Helicobacter pylori infections in the United States that are resistant to usual antibiotics.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Gastritis; Helicobac | 2002 |
[Dyspepsia and Helicobacter pylori infection in employees of a large industry. Results of a prospective BASF Helicobacter pylori prevention campaign].
Topics: Adolescent; Adult; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Female; Gastritis; Germany; | 2002 |
In vitro activity of rifampicin against Helicobacter pylori isolated from children and adults.
Topics: Adolescent; Adult; Amoxicillin; Biopsy; Child; Child, Preschool; Clarithromycin; Drug Resistance, Mu | 2002 |
Localization of antigen-presenting cells in Helicobacter pylori-infected gastric mucosa.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Antigen-Presenting Cells; CD28 Antigens; Cell Count; Clari | 2002 |
Prevalence of H. pylori-infection in family members of H. pylori positive and its influence on the reinfection rate after successful eradication therapy: a two-year follow-up.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Breath Tests; Child; Child, Preschool; Clarithromycin; D | 2002 |
[Treatment of "complete" erosions of the gastric mucosa].
Topics: Adult; Electrocoagulation; Female; Gastric Mucosa; Gastritis; Humans; Male; Metronidazole; Middle Ag | 1978 |
Clinicopathological assessment of gastric biopsy samples of patients with Helicobacter pylori infection--metronidazole resistance and compliance problems in the United Arab Emirates.
Topics: Adolescent; Adult; Antacids; Bacteriological Techniques; Bismuth; Doxycycline; Drug Resistance, Micr | 1992 |
Mucosal peptic activity during Helicobacter pylori infection in pediatric patients.
Topics: Adolescent; Amoxicillin; Child; Child, Preschool; Female; Gastric Mucosa; Gastritis; Helicobacter In | 1992 |
The role of Helicobacter pylori in the pathogenesis of acid-peptic disease.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Black or African American; Dyspepsia; Gastritis; Helicobac | 1992 |
In vitro activity of antifungal azoles against Helicobacter pylori.
Topics: Antifungal Agents; Gastritis; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Test | 1992 |
[Helicobacter pylori: from harmless commensal to clinically significant disease factor].
Topics: Amoxicillin; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Gastritis; Helicobacter | 1992 |
Factors influencing the eradication of Helicobacter pylori with triple therapy.
Topics: Adult; Aged; Aged, 80 and over; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastriti | 1992 |
[The treatment of patients with chronic gastritis].
Topics: Adult; Chronic Disease; Drug Evaluation; Female; Gastritis; Health Resorts; Helicobacter Infections; | 1991 |
Severe Helicobacter pylori infection in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Ampicillin; Animals; Biopsy; Drug Therapy, Combination; G | 1991 |
Susceptibility of Helicobacter pylori to metronidazole.
Topics: Amoxicillin; Chronic Disease; Drug Resistance, Microbial; Gastritis; Helicobacter pylori; Humans; Me | 1991 |
Plasma gastrin, daytime intragastric pH, and nocturnal acid output before and at 1 and 7 months after eradication of Helicobacter pylori in duodenal ulcer subjects.
Topics: Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Bismuth; Circadian Rhythm; Duodenal Ulcer; Female; Gast | 1991 |
Metronidazole-resistant Helicobacter pylori.
Topics: Adult; Aged; Campylobacter; Campylobacter Infections; Drug Resistance, Microbial; Female; Gastritis; | 1990 |
Antral Helicobacter pylori, hypergastrinaemia, and duodenal ulcers: effect of eradicating the organism.
Topics: Antacids; Campylobacter; Campylobacter Infections; Duodenal Ulcer; Gastrins; Gastritis; Humans; Metr | 1989 |
Campylobacter pylori in patients with dyspeptic symptoms and endoscopic evidence of erosion(s).
Topics: Adolescent; Adult; Aged; Bismuth; Campylobacter; Duodenitis; Dyspepsia; Endoscopy; Gastric Mucosa; G | 1989 |
[Search for the best procedure for Campylobacter eradication. Results of long-term studies are still unavailable].
Topics: Anti-Ulcer Agents; Campylobacter Infections; Drug Therapy, Combination; Follow-Up Studies; Gastritis | 1989 |
[Morphologic change in Campylobacter pylori associated gastritis in and following successful antibacterial therapy].
Topics: Amoxicillin; Bismuth; Campylobacter Infections; Drug Therapy, Combination; Gastric Mucosa; Gastritis | 1989 |
Susceptibility of clinical isolates of Campylobacter pyloridis to 11 antimicrobial agents.
Topics: Anti-Bacterial Agents; Bismuth; Campylobacter; Cefoxitin; Ciprofloxacin; Erythromycin; Gastritis; Ge | 1985 |